BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy1283
(123 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1NVP|B Chain B, Human TfiiaTBPDNA COMPLEX
Length = 57
Score = 57.4 bits (137), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 25/40 (62%), Positives = 33/40 (82%)
Query: 11 KLYQAVIADVINNVKEAFQEEGVDEQVLQELKHIWEAKLF 50
KLY++VI DVIN+V++ F ++GVDEQVL ELK +WE KL
Sbjct: 11 KLYRSVIEDVINDVRDIFLDDGVDEQVLMELKTLWENKLM 50
>pdb|1RM1|C Chain C, Structure Of A Yeast TfiiaTBPTATA-Box Dna Complex
Length = 286
Score = 51.6 bits (122), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 45/74 (60%), Gaps = 6/74 (8%)
Query: 11 KLYQAVIADVINNVKEAFQEEGVDEQVLQELKHIWEAKLFGIGVGKLSKRKEWMSKCYRS 70
++Y+ ++ V+N V+E F+ G+DEQ LQ+LK+IW+ KL V S W ++ +
Sbjct: 8 RVYEIIVESVVNEVREDFENAGIDEQTLQDLKNIWQKKLTETKVTTFS----WDNQ-FNE 62
Query: 71 SNISG-RPSLSGNL 83
NI+G + L+ NL
Sbjct: 63 GNINGVQNDLNFNL 76
>pdb|1YTF|B Chain B, Yeast TfiiaTBPDNA COMPLEX
pdb|1NH2|B Chain B, Crystal Structure Of A Yeast TfiiaTBPDNA COMPLEX
Length = 53
Score = 48.1 bits (113), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 18/39 (46%), Positives = 30/39 (76%)
Query: 11 KLYQAVIADVINNVKEAFQEEGVDEQVLQELKHIWEAKL 49
++Y+ ++ V+N V+E F+ G+DEQ LQ+LK+IW+ KL
Sbjct: 7 RVYEIIVESVVNEVREDFENAGIDEQTLQDLKNIWQKKL 45
>pdb|1RL8|A Chain A, Crystal Structure Of The Complex Of Resistant Strain Of
Hiv-1 Protease(v82a Mutant) With Ritonavir
pdb|1RL8|B Chain B, Crystal Structure Of The Complex Of Resistant Strain Of
Hiv-1 Protease(v82a Mutant) With Ritonavir
Length = 99
Score = 28.9 bits (63), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGAWKPKMIG-GIGGFIKVRQY 59
>pdb|1ODY|A Chain A, Hiv-1 Protease Complexed With An Inhibitor Lp-130
pdb|1ODY|B Chain B, Hiv-1 Protease Complexed With An Inhibitor Lp-130
Length = 99
Score = 28.9 bits (63), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGAWKPKMIG-GIGGFIKVRQY 59
>pdb|3U71|A Chain A, Crystal Structure Analysis Of South African Wild Type
Hiv-1 Subtype C Protease
Length = 99
Score = 28.5 bits (62), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 IKEALLDTGADDTVLEEINLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1A94|A Chain A, Structural Basis For Specificity Of Retroviral Proteases
pdb|1A94|B Chain B, Structural Basis For Specificity Of Retroviral Proteases
pdb|1A94|D Chain D, Structural Basis For Specificity Of Retroviral Proteases
pdb|1A94|E Chain E, Structural Basis For Specificity Of Retroviral Proteases
Length = 99
Score = 28.5 bits (62), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L WE K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWEPKMIG-GIGGFIKVRQY 59
>pdb|3OXV|B Chain B, Crystal Structure Of Hiv-1 I50v, A71 Protease In Complex
With The Protease Inhibitor Amprenavir.
pdb|3OXV|A Chain A, Crystal Structure Of Hiv-1 I50v, A71 Protease In Complex
With The Protease Inhibitor Amprenavir.
pdb|3OXV|D Chain D, Crystal Structure Of Hiv-1 I50v, A71 Protease In Complex
With The Protease Inhibitor Amprenavir.
pdb|3OXV|C Chain C, Crystal Structure Of Hiv-1 I50v, A71 Protease In Complex
With The Protease Inhibitor Amprenavir
Length = 99
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G GVG K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GVGGFIKVRQY 59
>pdb|3OXW|A Chain A, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Darunavir
pdb|3OXW|B Chain B, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Darunavir
pdb|3OXW|C Chain C, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Darunavir
pdb|3OXW|D Chain D, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Darunavir
pdb|3OXX|A Chain A, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Atazanavir
pdb|3OXX|B Chain B, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Atazanavir
pdb|3OXX|C Chain C, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Atazanavir
pdb|3OXX|D Chain D, Crystal Structure Of Hiv-1 I50v, A71v Protease In
Complex With The Protease Inhibitor Atazanavir
Length = 99
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G GVG K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GVGGFIKVRQY 59
>pdb|3R8R|A Chain A, Transaldolase From Bacillus Subtilis
pdb|3R8R|B Chain B, Transaldolase From Bacillus Subtilis
pdb|3R8R|C Chain C, Transaldolase From Bacillus Subtilis
pdb|3R8R|D Chain D, Transaldolase From Bacillus Subtilis
pdb|3R8R|E Chain E, Transaldolase From Bacillus Subtilis
pdb|3R8R|F Chain F, Transaldolase From Bacillus Subtilis
pdb|3R8R|G Chain G, Transaldolase From Bacillus Subtilis
pdb|3R8R|H Chain H, Transaldolase From Bacillus Subtilis
pdb|3R8R|I Chain I, Transaldolase From Bacillus Subtilis
pdb|3R8R|J Chain J, Transaldolase From Bacillus Subtilis
pdb|3R8R|V Chain V, Transaldolase From Bacillus Subtilis
pdb|3R8R|K Chain K, Transaldolase From Bacillus Subtilis
pdb|3R8R|L Chain L, Transaldolase From Bacillus Subtilis
pdb|3R8R|M Chain M, Transaldolase From Bacillus Subtilis
pdb|3R8R|N Chain N, Transaldolase From Bacillus Subtilis
pdb|3R8R|W Chain W, Transaldolase From Bacillus Subtilis
pdb|3R8R|P Chain P, Transaldolase From Bacillus Subtilis
pdb|3R8R|R Chain R, Transaldolase From Bacillus Subtilis
pdb|3R8R|T Chain T, Transaldolase From Bacillus Subtilis
pdb|3R8R|U Chain U, Transaldolase From Bacillus Subtilis
Length = 212
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 14/43 (32%), Positives = 25/43 (58%), Gaps = 4/43 (9%)
Query: 19 DVINNVKEAFQEEGVDEQV----LQELKHIWEAKLFGIGVGKL 57
D+I+ VK+ F G+D Q+ ++ +H+ EA L G +G +
Sbjct: 143 DLISEVKQIFDIHGLDTQIIAASIRHPQHVTEAALRGAHIGTM 185
>pdb|3MWS|A Chain A, Crystal Structure Of Group N Hiv-1 Protease
pdb|3MWS|B Chain B, Crystal Structure Of Group N Hiv-1 Protease
Length = 99
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 40/78 (51%), Gaps = 10/78 (12%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEWMSKCYRSSNISGRPS--- 78
V+EA + G D+ V++E L+ W+ K+ G G+G K +++ + +I GR +
Sbjct: 19 VREALLDTGADDTVIEEIQLEGKWKPKMIG-GIGGFIKVRQYDNVTI---DIQGRKAVGT 74
Query: 79 -LSGNLKARLVYQPCLTQ 95
L G ++ + LTQ
Sbjct: 75 VLVGPTPVNIIGRNFLTQ 92
>pdb|3OU1|B Chain B, Mdr769 Hiv-1 Protease Complexed With RhIN HEPTA-Peptide
pdb|3OU4|B Chain B, Mdr769 Hiv-1 Protease Complexed With TfPR HEPTA-Peptide
Length = 99
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|2O4L|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, I50v) In
Complex With Tipranavir
pdb|2O4L|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, I50v) In
Complex With Tipranavir
Length = 99
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G GVG K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GVGGFIKVRQY 59
>pdb|2G69|A Chain A, Structure Of Unliganded Hiv-1 Protease F53l Mutant
Length = 99
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G L K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGLIKVRQY 59
>pdb|2R3T|A Chain A, I50v Hiv-1 Protease Mutant In Complex With A Carbamoyl
Decorated Pyrrolidine-Based Inhibitor
pdb|2R3T|B Chain B, I50v Hiv-1 Protease Mutant In Complex With A Carbamoyl
Decorated Pyrrolidine-Based Inhibitor
pdb|2R43|A Chain A, I50v Hiv-1 Protease In Complex With An Amino Decorated
Pyrrolidine- Based Inhibitor
pdb|2R43|B Chain B, I50v Hiv-1 Protease In Complex With An Amino Decorated
Pyrrolidine- Based Inhibitor
Length = 99
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G GVG K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GVGGFIKVRQY 59
>pdb|3OTY|A Chain A, Mdr769 Hiv-1 Protease Complexed With RtRH HEPTA-Peptide
pdb|3OTY|B Chain B, Mdr769 Hiv-1 Protease Complexed With RtRH HEPTA-Peptide
pdb|3OU1|A Chain A, Mdr769 Hiv-1 Protease Complexed With RhIN HEPTA-Peptide
pdb|3OU3|A Chain A, Mdr769 Hiv-1 Protease Complexed With PrRT HEPTA-Peptide
pdb|3OU3|B Chain B, Mdr769 Hiv-1 Protease Complexed With PrRT HEPTA-Peptide
pdb|3OU4|A Chain A, Mdr769 Hiv-1 Protease Complexed With TfPR HEPTA-Peptide
pdb|3OUA|A Chain A, Mdr769 Hiv-1 Protease Complexed With P1P6 HEPTA-Peptide
pdb|3OUA|B Chain B, Mdr769 Hiv-1 Protease Complexed With P1P6 HEPTA-Peptide
pdb|3OUB|A Chain A, Mdr769 Hiv-1 Protease Complexed With NcP1 HEPTA-Peptide
pdb|3OUB|B Chain B, Mdr769 Hiv-1 Protease Complexed With NcP1 HEPTA-Peptide
pdb|3OUC|A Chain A, Mdr769 Hiv-1 Protease Complexed With P2NC HEPTA-Peptide
pdb|3OUC|B Chain B, Mdr769 Hiv-1 Protease Complexed With P2NC HEPTA-Peptide
pdb|3OUD|A Chain A, Mdr769 Hiv-1 Protease Complexed With CaP2 HEPTA-Peptide
pdb|3OQ7|A Chain A, Crystal Structures Of Multidrug-resistant Clinical
Isolate 769 Hiv-1 Protease Variants
pdb|3R0W|A Chain A, Crystal Structures Of Multidrug-Resistant Hiv-1 Protease
In Complex With Mechanism-Based Aspartyl Protease
Inhibitors.
pdb|3R0W|B Chain B, Crystal Structures Of Multidrug-Resistant Hiv-1 Protease
In Complex With Mechanism-Based Aspartyl Protease
Inhibitors.
pdb|3R0Y|A Chain A, Crystal Structures Of Multidrug-Resistant Hiv-1 Protease
In Complex With Mechanism-Based Aspartyl Protease
Inhibitors
pdb|3R0Y|B Chain B, Crystal Structures Of Multidrug-Resistant Hiv-1 Protease
In Complex With Mechanism-Based Aspartyl Protease
Inhibitors
pdb|4FAE|A Chain A, Substrate P2NC IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY
VIRUS TYPE 1 Protease Variant
pdb|4FAE|B Chain B, Substrate P2NC IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY
VIRUS TYPE 1 Protease Variant
pdb|4FAF|A Chain A, Substrate CaP2 IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY
VIRUS TYPE 1 Protease Variant
pdb|4FAF|B Chain B, Substrate CaP2 IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY
VIRUS TYPE 1 Protease Variant
pdb|4EYR|A Chain A, Crystal Structure Of Multidrug-resistant Clinical
Isolate 769 Hiv-1 Protease In Complex With Ritonavir
pdb|4EYR|B Chain B, Crystal Structure Of Multidrug-resistant Clinical
Isolate 769 Hiv-1 Protease In Complex With Ritonavir
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|3SO9|A Chain A, Darunavir In Complex With A Human Immunodeficiency Virus
Type 1 Protease Variant
pdb|3SO9|B Chain B, Darunavir In Complex With A Human Immunodeficiency Virus
Type 1 Protease Variant
pdb|3SPK|A Chain A, Tipranavir In Complex With A Human Immunodeficiency
Virus Type 1 Protease Variant
pdb|3SPK|B Chain B, Tipranavir In Complex With A Human Immunodeficiency
Virus Type 1 Protease Variant
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|3OQA|A Chain A, Crystal Structures Of Multidrug-Resistant Clinical
Isolate 769 Hiv-1 Protease Variants
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|3PJ6|A Chain A, Crystal Structures Of Multidrug-Resistant Clinical
Isolate 769 Hiv-1 Protease Variants
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|1RPI|A Chain A, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1RPI|B Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1RQ9|A Chain A, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1RQ9|B Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1RV7|A Chain A, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1RV7|B Chain B, Crystal Structures Of A Multidrug-Resistant Hiv-1
Protease Reveal An Expanded Active Site Cavity
pdb|1TW7|A Chain A, Wide Open 1.3a Structure Of A Multi-Drug Resistant Hiv-1
Protease Represents A Novel Drug Target
pdb|1TW7|B Chain B, Wide Open 1.3a Structure Of A Multi-Drug Resistant Hiv-1
Protease Represents A Novel Drug Target
pdb|3OTS|A Chain A, Mdr769 Hiv-1 Protease Complexed With MaCA HEPTA-Peptide
pdb|3OTS|B Chain B, Mdr769 Hiv-1 Protease Complexed With MaCA HEPTA-Peptide
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|1K6C|A Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-drug
Resistant Hiv-1 Protease
pdb|1K6C|B Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-drug
Resistant Hiv-1 Protease
pdb|1K6P|A Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1K6P|B Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1K6T|A Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1K6T|B Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1K6V|A Chain A, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1K6V|B Chain B, Lack Of Synergy For Inhibitors Targeting A Multi-Drug
Resistant Hiv-1 Protease
pdb|1T7I|A Chain A, The Structural And Thermodynamic Basis For The Binding
Of Tmc114, A Next-Generation Hiv-1 Protease Inhibitor.
pdb|1T7I|B Chain B, The Structural And Thermodynamic Basis For The Binding
Of Tmc114, A Next-Generation Hiv-1 Protease Inhibitor.
pdb|1T7J|A Chain A, Crystal Structure Of Inhibitor Amprenavir In Complex
With A Multi-Drug Resistant Variant Of Hiv-1 Protease
(L63pV82TI84V)
pdb|1T7J|B Chain B, Crystal Structure Of Inhibitor Amprenavir In Complex
With A Multi-Drug Resistant Variant Of Hiv-1 Protease
(L63pV82TI84V)
pdb|3EL5|A Chain A, Crystal Structure Of Nelfinavir (Nfv) Complexed With A
Multidrug Variant (Act) (V82tI84V) OF HIV-1 Protease
pdb|3EL5|B Chain B, Crystal Structure Of Nelfinavir (Nfv) Complexed With A
Multidrug Variant (Act) (V82tI84V) OF HIV-1 Protease
Length = 99
Score = 28.1 bits (61), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3P0U|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Testicular Receptor 4
pdb|3P0U|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Testicular Receptor 4
Length = 249
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 11/44 (25%), Positives = 29/44 (65%), Gaps = 1/44 (2%)
Query: 15 AVIADVINNVKEAFQEEGVD-EQVLQELKHIWEAKLFGIGVGKL 57
++A ++N+++ + QE+ + +++ Q ++HIW+ + F + KL
Sbjct: 95 TILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKL 138
>pdb|3OQD|A Chain A, Crystal Structures Of Multidrug-Resistant Clinical
Isolate 769 Hiv-1 Protease Variants
Length = 99
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ KL G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEVNLPGRWKPKLIG-GIGGFVKVRQY 59
>pdb|2WL0|A Chain A, Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol
In The Transition-State Mimic With Improved Cell-Based
Antiviral Activity
pdb|2WL0|B Chain B, Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol
In The Transition-State Mimic With Improved Cell-Based
Antiviral Activity
pdb|2XYE|A Chain A, Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing
Transition-State Mimic And Various P2 And P1 Prime
Substituents
pdb|2XYE|B Chain B, Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing
Transition-State Mimic And Various P2 And P1 Prime
Substituents
pdb|2XYF|A Chain A, Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing
Transition-State Mimic And Various P2 And P1 Prime
Substituents
pdb|2XYF|B Chain B, Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing
Transition-State Mimic And Various P2 And P1 Prime
Substituents
pdb|4A6B|A Chain A, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
pdb|4A6B|B Chain B, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
pdb|4A6C|A Chain A, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
pdb|4A6C|B Chain B, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
pdb|4A4Q|A Chain A, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
pdb|4A4Q|B Chain B, Stereoselective Synthesis, X-Ray Analysis, And
Biological Evaluation Of A New Class Of Lactam Based
Hiv-1 Protease Inhibitors
Length = 99
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3EL4|A Chain A, Crystal Structure Of Inhibitor Saquinavir (Sqv)
Complexed With The Multidrug Hiv-1 Protease Variant
L63pV82TI84V
pdb|3EL4|B Chain B, Crystal Structure Of Inhibitor Saquinavir (Sqv)
Complexed With The Multidrug Hiv-1 Protease Variant
L63pV82TI84V
Length = 99
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2F3K|A Chain A, Substrate Envelope And Drug Resistance: Crystal
Structure Of R01 In Complex With Wild-Type Hiv-1
Protease
pdb|2F3K|B Chain B, Substrate Envelope And Drug Resistance: Crystal
Structure Of R01 In Complex With Wild-Type Hiv-1
Protease
pdb|2I0A|A Chain A, Crystal Structure Of Kb-19 Complexed With Wild Type
Hiv-1 Protease
pdb|2I0A|B Chain B, Crystal Structure Of Kb-19 Complexed With Wild Type
Hiv-1 Protease
pdb|2I0D|A Chain A, Crystal Structure Of Ad-81 Complexed With Wild Type
Hiv-1 Protease
pdb|2I0D|B Chain B, Crystal Structure Of Ad-81 Complexed With Wild Type
Hiv-1 Protease
pdb|2PSU|A Chain A, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
With Carb- Ad37
pdb|2PSU|B Chain B, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
With Carb- Ad37
pdb|2PSV|A Chain A, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
With Carb- Kb45
pdb|2PSV|B Chain B, Crystal Structure Of Wild Type Hiv-1 Protease In Complex
With Carb- Kb45
pdb|2Q54|A Chain A, Crystal Structure Of Kb73 Bound To Hiv-1 Protease
pdb|2Q54|B Chain B, Crystal Structure Of Kb73 Bound To Hiv-1 Protease
pdb|2Q55|A Chain A, Crystal Structure Of Kk44 Bound To Hiv-1 Protease
pdb|2Q55|B Chain B, Crystal Structure Of Kk44 Bound To Hiv-1 Protease
pdb|2Q5K|A Chain A, Crystal Structure Of Lopinavir Bound To Wild Type Hiv-1
Protease
pdb|2Q5K|B Chain B, Crystal Structure Of Lopinavir Bound To Wild Type Hiv-1
Protease
pdb|2Q3K|A Chain A, Crystal Structure Of Lysine Sulfonamide Inhibitor
Reveals The Displacement Of The Conserved Flap Water
Molecule In Hiv-1 Protease
pdb|2Q3K|B Chain B, Crystal Structure Of Lysine Sulfonamide Inhibitor
Reveals The Displacement Of The Conserved Flap Water
Molecule In Hiv-1 Protease
pdb|2QHY|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Ac86 In
Complex With Wild Type Hiv-1 Protease
pdb|2QHY|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Ac86 In
Complex With Wild Type Hiv-1 Protease
pdb|2QHZ|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Ac87 In
Complex With Wild Type Hiv-1 Protease
pdb|2QHZ|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Ac87 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI0|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Kk80 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI0|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Kk80 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI1|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-1-Kk81 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI1|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-1-Kk81 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI3|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-ad94 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI3|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-ad94 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI4|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Ad93 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI4|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Ad93 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI5|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Kc08 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI5|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Kc08 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI6|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Kb98 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI6|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Kb98 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI7|A Chain A, Crystal Structure Of Protease Inhibitor, Mit-2-Ad86 In
Complex With Wild Type Hiv-1 Protease
pdb|2QI7|B Chain B, Crystal Structure Of Protease Inhibitor, Mit-2-Ad86 In
Complex With Wild Type Hiv-1 Protease
pdb|3EKV|A Chain A, Crystal Structure Of The Wild Type Hiv-1 Protease With
The Inhibitor, Amprenavir
pdb|3EKV|B Chain B, Crystal Structure Of The Wild Type Hiv-1 Protease With
The Inhibitor, Amprenavir
pdb|3EKX|A Chain A, Crystal Structure Of The Wild-Type Hiv-1 Protease With
The Inhibitor, Nelfinavir
pdb|3EKX|B Chain B, Crystal Structure Of The Wild-Type Hiv-1 Protease With
The Inhibitor, Nelfinavir
pdb|3EKY|A Chain A, Crystal Structure Of Wild-Type Hiv Protease In Complex
With The Inhibitor, Atazanavir
pdb|3EKY|B Chain B, Crystal Structure Of Wild-Type Hiv Protease In Complex
With The Inhibitor, Atazanavir
pdb|3GI4|A Chain A, Crystal Structure Of Protease Inhibitor, Kb60 In Complex
With Wild Type Hiv-1 Protease
pdb|3GI4|B Chain B, Crystal Structure Of Protease Inhibitor, Kb60 In Complex
With Wild Type Hiv-1 Protease
pdb|3GI5|A Chain A, Crystal Structure Of Protease Inhibitor, Kb62 In Complex
With Wild Type Hiv-1 Protease
pdb|3GI5|B Chain B, Crystal Structure Of Protease Inhibitor, Kb62 In Complex
With Wild Type Hiv-1 Protease
pdb|3GI6|A Chain A, Crystal Structure Of Protease Inhibitor, Ad78 In Complex
With Wild Type Hiv-1 Protease
pdb|3GI6|B Chain B, Crystal Structure Of Protease Inhibitor, Ad78 In Complex
With Wild Type Hiv-1 Protease
pdb|3MXD|A Chain A, Crystal Structure Of Hiv-1 Protease Inhibitor Kc53 In
Complex With Wild-Type Protease
pdb|3MXD|B Chain B, Crystal Structure Of Hiv-1 Protease Inhibitor Kc53 In
Complex With Wild-Type Protease
pdb|3MXE|A Chain A, Crystal Structure Of Hiv-1 Protease Inhibitor, Kc32
Complexed With Wild-type Protease
pdb|3MXE|B Chain B, Crystal Structure Of Hiv-1 Protease Inhibitor, Kc32
Complexed With Wild-type Protease
pdb|3O99|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd13
pdb|3O99|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd13
pdb|3O9A|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd14
pdb|3O9A|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd14
pdb|3O9B|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd25
pdb|3O9B|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd25
pdb|3O9C|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd20
pdb|3O9C|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd20
pdb|3O9D|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd19
pdb|3O9D|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd19
pdb|3O9E|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af60
pdb|3O9E|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af60
pdb|3O9F|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd27
pdb|3O9F|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd27
pdb|3O9G|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af53
pdb|3O9G|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af53
pdb|3O9H|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd26
pdb|3O9H|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kd26
pdb|3O9I|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af61
pdb|3O9I|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af61
pdb|3R4B|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Tmc310911
pdb|3R4B|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Tmc310911
pdb|3SA3|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Ag23
pdb|3SA3|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Ag23
pdb|3SA4|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af72
pdb|3SA4|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af72
pdb|3SA5|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af69
pdb|3SA5|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af69
pdb|3SA6|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af71
pdb|3SA6|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af71
pdb|3SA7|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af55
pdb|3SA7|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af55
pdb|3SA8|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kb83
pdb|3SA8|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Kb83
pdb|3SA9|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af68
pdb|3SA9|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af68
pdb|3SAA|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af77
pdb|3SAA|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af77
pdb|3SAB|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af78
pdb|3SAB|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af78
pdb|3SAC|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af80
pdb|3SAC|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Af80
pdb|4DJO|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp56
pdb|4DJO|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp56
pdb|4DJP|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp73
pdb|4DJP|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp73
pdb|4DJQ|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp86
pdb|4DJQ|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp86
pdb|4DJR|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp97
pdb|4DJR|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Mkp97
Length = 99
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2FDE|A Chain A, Wild Type Hiv Protease Bound With Gw0385
pdb|2FDE|B Chain B, Wild Type Hiv Protease Bound With Gw0385
Length = 100
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 18 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 60
>pdb|3EL9|A Chain A, Crystal Structure Of Atazanavir (Atv) In Complex With A
Multidrug Hiv- 1 Protease (V82tI84V)
pdb|3EL9|B Chain B, Crystal Structure Of Atazanavir (Atv) In Complex With A
Multidrug Hiv- 1 Protease (V82tI84V)
Length = 99
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|3KT5|A Chain A, Crystal Structure Of N88s Mutant Hiv-1 Protease
Length = 203
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 121 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 163
>pdb|1YTG|A Chain A, Siv Protease Crystallized With Peptide Product
pdb|1YTG|B Chain B, Siv Protease Crystallized With Peptide Product
pdb|1YTH|A Chain A, Siv Protease Crystallized With Peptide Product
pdb|1YTH|B Chain B, Siv Protease Crystallized With Peptide Product
pdb|2AID|A Chain A, Structure Of A Non-Peptide Inhibitor Complexed With
Hiv-1 Protease: Developing A Cycle Of Structure-Based
Drug Design
pdb|2AID|B Chain B, Structure Of A Non-Peptide Inhibitor Complexed With
Hiv-1 Protease: Developing A Cycle Of Structure-Based
Drug Design
pdb|1T3R|A Chain A, Hiv Protease Wild-type In Complex With Tmc114 Inhibitor
pdb|1T3R|B Chain B, Hiv Protease Wild-type In Complex With Tmc114 Inhibitor
pdb|1KZK|A Chain A, Je-2147-Hiv Protease Complex
pdb|1KZK|B Chain B, Je-2147-Hiv Protease Complex
pdb|3EL1|A Chain A, Crystal Structure Of Wild-Type Hiv Protease In Complex
With The Inhibitor, Atazanavir
pdb|3EL1|B Chain B, Crystal Structure Of Wild-Type Hiv Protease In Complex
With The Inhibitor, Atazanavir
pdb|3I7E|A Chain A, Co-Crystal Structure Of Hiv-1 Protease Bound To A Mutant
Resistant Inhibitor Uic-98038
pdb|3I7E|B Chain B, Co-Crystal Structure Of Hiv-1 Protease Bound To A Mutant
Resistant Inhibitor Uic-98038
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1AID|A Chain A, Structure Of A Non-Peptide Inhibitor Complexed With
Hiv-1 Protease: Developing A Cycle Of Structure-Based
Drug Design
pdb|1AID|B Chain B, Structure Of A Non-Peptide Inhibitor Complexed With
Hiv-1 Protease: Developing A Cycle Of Structure-Based
Drug Design
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2PYN|A Chain A, Hiv-1 Pr Mutant In Complex With Nelfinavir
pdb|2PYN|B Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADNTVLEEMSLPGAWKPKMIG-GIGGFIKVRQY 59
>pdb|2FGV|A Chain A, X-Ray Crystal Structure Of Hiv-1 Protease T80n Variant
In Complex With The Inhibitor Saquinavir Used To
Explore The Role Of Invariant Thr80 In Hiv-1 Protease
Structure, Function, And Viral Infectivity.
pdb|2FGV|B Chain B, X-Ray Crystal Structure Of Hiv-1 Protease T80n Variant
In Complex With The Inhibitor Saquinavir Used To
Explore The Role Of Invariant Thr80 In Hiv-1 Protease
Structure, Function, And Viral Infectivity
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|3OY4|A Chain A, Crystal Structure Of Hiv-1 L76v Protease In Complex With
The Protease Inhibitor Darunavir.
pdb|3OY4|B Chain B, Crystal Structure Of Hiv-1 L76v Protease In Complex With
The Protease Inhibitor Darunavir
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2Q64|A Chain A, Hiv-1 Pr Mutant In Complex With Nelfinavir
pdb|2Q64|B Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADNTVLEEMSLPGAWKPKMIG-GIGGFIKVRQY 59
>pdb|2FGU|A Chain A, X-Ray Crystal Structure Of Hiv-1 Protease T80s Variant
In Complex With The Inhibitor Saquinavir Used To
Explore The Role Of Invariant Thr80 In Hiv-1 Protease
Structure, Function, And Viral Infectivity.
pdb|2FGU|B Chain B, X-Ray Crystal Structure Of Hiv-1 Protease T80s Variant
In Complex With The Inhibitor Saquinavir Used To
Explore The Role Of Invariant Thr80 In Hiv-1 Protease
Structure, Function, And Viral Infectivity
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1LZQ|A Chain A, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (A71v, V82t, I84v) With An Ethylenamine
Peptidomimetic Inhibitor Boc-Phe-
Psi[ch2ch2nh]-Phe-Glu-Phe-Nh2
pdb|1LZQ|B Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (A71v, V82t, I84v) With An Ethylenamine
Peptidomimetic Inhibitor Boc-Phe-
Psi[ch2ch2nh]-Phe-Glu-Phe-Nh2
pdb|1ZLF|A Chain A, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
(A71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor
pdb|1ZLF|B Chain B, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
(A71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor
pdb|1ZJ7|A Chain A, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
(A71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor Boc-Phe-
Psi[s-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1Z8C|A Chain A, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (L63p, A71v, V82t, I84v) With A
Hydroxyethylamine Peptidomimetic Inhibitor Boc-
Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
pdb|1Z8C|B Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (L63p, A71v, V82t, I84v) With A
Hydroxyethylamine Peptidomimetic Inhibitor Boc-
Phe-Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
Length = 99
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1GNN|A Chain A, Hiv-1 Protease Mutant With Val 82 Replaced By Asn (V82n)
Complexed With U89360e (Inhibitor)
pdb|1GNN|B Chain B, Hiv-1 Protease Mutant With Val 82 Replaced By Asn (V82n)
Complexed With U89360e (Inhibitor)
Length = 99
Score = 28.1 bits (61), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1ODX|A Chain A, Hiv-1 Proteinase Mutant A71t, V82a
pdb|1ODX|B Chain B, Hiv-1 Proteinase Mutant A71t, V82a
Length = 99
Score = 28.1 bits (61), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3TLH|A Chain A, Structural Studies Of Hiv And Fiv Proteases Complexed
Withan Efficient Inhibitor Of Fiv Pr
pdb|1ZPA|A Chain A, Hiv Protease With Scripps Ab-3 Inhibitor
pdb|1ZP8|A Chain A, Hiv Protease With Inhibitor Ab-2
pdb|2O4K|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex
With Atazanavir
pdb|2O4K|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex
With Atazanavir
pdb|2O4P|A Chain A, Crystal Structure Of Hiv-1 Protease (q7k) In Complex
With Tipranavir
pdb|2O4P|B Chain B, Crystal Structure Of Hiv-1 Protease (q7k) In Complex
With Tipranavir
pdb|2O4S|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex
With Lopinavir
pdb|2O4S|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k) In Complex
With Lopinavir
pdb|2P3B|A Chain A, Crystal Structure Of The Subtype B Wild Type Hiv
Protease Complexed With Tl-3 Inhibitor
Length = 99
Score = 28.1 bits (61), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1IZI|A Chain A, Inhibitor Of Hiv Protease With Unusual Binding Mode
Potently Inhibiting Multi-Resistant Protease Mutants
pdb|1IZI|B Chain B, Inhibitor Of Hiv Protease With Unusual Binding Mode
Potently Inhibiting Multi-Resistant Protease Mutants
Length = 99
Score = 28.1 bits (61), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3KT2|A Chain A, Crystal Structure Of N88d Mutant Hiv-1 Protease
Length = 203
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 121 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 163
>pdb|2PYM|A Chain A, Hiv-1 Pr Mutant In Complex With Nelfinavir
pdb|2PYM|B Chain B, Hiv-1 Pr Mutant In Complex With Nelfinavir
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADNTVLEEMSLPGAWKPKMIG-GIGGFIKVRQY 59
>pdb|2AZ9|A Chain A, Hiv-1 Protease Nl4-3 1x Mutant
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HOS|A Chain A, Inhibition Of Human Immunodeficiency Virus-1 Protease By
A C2- Symmetric Phosphinate Synthesis And
Crystallographic Analysis
pdb|1HOS|B Chain B, Inhibition Of Human Immunodeficiency Virus-1 Protease By
A C2- Symmetric Phosphinate Synthesis And
Crystallographic Analysis
pdb|1HTE|A Chain A, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HTE|B Chain B, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HTF|A Chain A, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HTF|B Chain B, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HTG|A Chain A, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HTG|B Chain B, X-Ray Crystallographic Studies Of A Series Of
Penicillin- Derived Asymmetric Inhibitors Of Hiv-1
Protease
pdb|1HPS|A Chain A, Rational Design, Synthesis And Crystallographic Analysis
Of A Hydroxyethylene-Based Hiv-1 Protease Inhibitor
Containing A Heterocyclic P1'-P2' Amide Bond Isostere
pdb|1HPS|B Chain B, Rational Design, Synthesis And Crystallographic Analysis
Of A Hydroxyethylene-Based Hiv-1 Protease Inhibitor
Containing A Heterocyclic P1'-P2' Amide Bond Isostere
pdb|1HPV|A Chain A, Crystal Structure Of Hiv-1 Protease In Complex With
Vx-478, A Potent And Orally Bioavailable Inhibitor Of
The Enzyme
pdb|1HPV|B Chain B, Crystal Structure Of Hiv-1 Protease In Complex With
Vx-478, A Potent And Orally Bioavailable Inhibitor Of
The Enzyme
pdb|1HBV|A Chain A, A Check On Rational Drug Design. Crystal Structure Of A
Complex Of Hiv-1 Protease With A Novel Gamma-Turn
Mimetic
pdb|1HBV|B Chain B, A Check On Rational Drug Design. Crystal Structure Of A
Complex Of Hiv-1 Protease With A Novel Gamma-Turn
Mimetic
pdb|1HIH|A Chain A, Comparative Analysis Of The X-Ray Structures Of Hiv-1
And Hiv-2 Proteases In Complex With Cgp 53820, A Novel
Pseudosymmetric Inhibitor
pdb|1HIH|B Chain B, Comparative Analysis Of The X-Ray Structures Of Hiv-1
And Hiv-2 Proteases In Complex With Cgp 53820, A Novel
Pseudosymmetric Inhibitor
pdb|1HPX|A Chain A, Hiv-1 Protease Complexed With The Inhibitor Kni-272
pdb|1HPX|B Chain B, Hiv-1 Protease Complexed With The Inhibitor Kni-272
pdb|1HSG|A Chain A, Crystal Structure At 1.9 Angstroms Resolution Of Human
Immunodeficiency Virus (Hiv) Ii Protease Complexed With
L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
Proteases
pdb|1HSG|B Chain B, Crystal Structure At 1.9 Angstroms Resolution Of Human
Immunodeficiency Virus (Hiv) Ii Protease Complexed With
L- 735,524, An Orally Bioavailable Inhibitor Of The Hiv
Proteases
pdb|2UPJ|A Chain A, Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl
[4-Hydroxy-
2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl]
Methyl]phenyl]amino]- 3-Oxo-Propyl]carbamic Acid
Tert-Butyl Ester)
pdb|2UPJ|B Chain B, Hiv-1 Protease Complex With U100313 ([3-[[3-[cyclopropyl
[4-Hydroxy-
2oxo-6-[1-(Phenylmethyl)propyl]-2h-Pyran-3-Yl]
Methyl]phenyl]amino]- 3-Oxo-Propyl]carbamic Acid
Tert-Butyl Ester)
pdb|1GNO|A Chain A, Hiv-1 Protease (Wild Type) Complexed With U89360e
(Inhibitor)
pdb|1GNO|B Chain B, Hiv-1 Protease (Wild Type) Complexed With U89360e
(Inhibitor)
pdb|7UPJ|A Chain A, Hiv-1 ProteaseU101935 COMPLEX
pdb|7UPJ|B Chain B, Hiv-1 ProteaseU101935 COMPLEX
pdb|1AJV|A Chain A, Hiv-1 Protease In Complex With The Cyclic Sulfamide
Inhibitor Aha006
pdb|1AJV|B Chain B, Hiv-1 Protease In Complex With The Cyclic Sulfamide
Inhibitor Aha006
pdb|1AJX|A Chain A, Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor
Aha001
pdb|1AJX|B Chain B, Hiv-1 Protease In Complex With The Cyclic Urea Inhibitor
Aha001
pdb|2BPV|A Chain A, Hiv-1 Protease-Inhibitor Complex
pdb|2BPV|B Chain B, Hiv-1 Protease-Inhibitor Complex
pdb|2BPW|A Chain A, Hiv-1 Protease-Inhibitor Complex
pdb|2BPW|B Chain B, Hiv-1 Protease-Inhibitor Complex
pdb|2BPX|A Chain A, Hiv-1 Protease-Inhibitor Complex
pdb|2BPX|B Chain B, Hiv-1 Protease-Inhibitor Complex
pdb|2BPY|A Chain A, Hiv-1 Protease-Inhibitor Complex
pdb|2BPY|B Chain B, Hiv-1 Protease-Inhibitor Complex
pdb|2BPZ|A Chain A, Hiv-1 Protease-Inhibitor Complex
pdb|2BPZ|B Chain B, Hiv-1 Protease-Inhibitor Complex
pdb|1C70|A Chain A, Alternate Binding Site For The P1-P3 Group Of A Class Of
Potent Hiv-1 Protease Inhibitors As A Result Of
Concerted Structural Change In 80's Loop.
pdb|1C70|B Chain B, Alternate Binding Site For The P1-P3 Group Of A Class Of
Potent Hiv-1 Protease Inhibitors As A Result Of
Concerted Structural Change In 80's Loop.
pdb|1FQX|A Chain A, Crystal Structure Of The Complex Of Hiv-1 Protease With
A Peptidomimetic Inhibitor
pdb|1FQX|B Chain B, Crystal Structure Of The Complex Of Hiv-1 Protease With
A Peptidomimetic Inhibitor
pdb|1G35|A Chain A, Crystal Structure Of Hiv-1 Protease In Complex With
Inhibitor, Aha024
pdb|1G35|B Chain B, Crystal Structure Of Hiv-1 Protease In Complex With
Inhibitor, Aha024
pdb|1G2K|A Chain A, Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047
pdb|1G2K|B Chain B, Hiv-1 Protease With Cyclic Sulfamide Inhibitor, Aha047
pdb|1IIQ|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With A
Hydroxyethylamine Peptidomimetic Inhibitor
pdb|1IIQ|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With A
Hydroxyethylamine Peptidomimetic Inhibitor
pdb|1D4H|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea435
pdb|1D4H|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea435
pdb|1D4I|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea425
pdb|1D4I|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea425
pdb|1D4J|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Msl370
pdb|1D4J|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Msl370
pdb|1EBW|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea322
pdb|1EBW|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea322
pdb|1EBZ|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea388
pdb|1EBZ|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea388
pdb|1EC0|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea403
pdb|1EC0|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea403
pdb|1EC1|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea409
pdb|1EC1|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea409
pdb|1EC2|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea428
pdb|1EC2|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea428
pdb|1EC3|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Msa367
pdb|1EC3|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Msa367
pdb|1MUI|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With
Lopinavir.
pdb|1MUI|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With
Lopinavir.
pdb|1NPV|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With
Ldc271
pdb|1NPV|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With
Ldc271
pdb|1NPW|A Chain A, Crystal Structure Of Hiv Protease Complexed With Lgz479
pdb|1NPW|B Chain B, Crystal Structure Of Hiv Protease Complexed With Lgz479
pdb|1M0B|A Chain A, Hiv-1 Protease In Complex With An Ethyleneamine
Inhibitor
pdb|1M0B|B Chain B, Hiv-1 Protease In Complex With An Ethyleneamine
Inhibitor
pdb|1NPA|A Chain A, Crystal Structure Of Hiv-1 Protease-Hup
pdb|1NPA|B Chain B, Crystal Structure Of Hiv-1 Protease-Hup
pdb|1NH0|A Chain A, 1.03 A Structure Of Hiv-1 Protease: Inhibitor Binding
Inside And Outside The Active Site
pdb|1NH0|B Chain B, 1.03 A Structure Of Hiv-1 Protease: Inhibitor Binding
Inside And Outside The Active Site
pdb|1T7K|A Chain A, Crystal Structure Of Hiv Protease Complexed With
Arylsulfonamide Azacyclic Urea
pdb|1T7K|B Chain B, Crystal Structure Of Hiv Protease Complexed With
Arylsulfonamide Azacyclic Urea
pdb|1U8G|A Chain A, Crystal Structure Of A Hiv-1 Protease In Complex With
Peptidomimetic Inhibitor Ki2-Phe-Glu-Glu-Nh2
pdb|1U8G|B Chain B, Crystal Structure Of A Hiv-1 Protease In Complex With
Peptidomimetic Inhibitor Ki2-Phe-Glu-Glu-Nh2
pdb|1WBK|A Chain A, Hiv-1 Protease In Complex With Asymmetric Inhibitor,
Bea568
pdb|1WBK|B Chain B, Hiv-1 Protease In Complex With Asymmetric Inhibitor,
Bea568
pdb|1WBM|A Chain A, Hiv-1 Protease In Complex With Symmetric Inhibitor,
Bea450
pdb|1WBM|B Chain B, Hiv-1 Protease In Complex With Symmetric Inhibitor,
Bea450
pdb|1YT9|A Chain A, Hiv Protease With Oximinoarylsulfonamide Bound
pdb|1YT9|B Chain B, Hiv Protease With Oximinoarylsulfonamide Bound
pdb|1XL2|A Chain A, Hiv-1 Protease In Complex With Pyrrolidinmethanamine
pdb|1XL2|B Chain B, Hiv-1 Protease In Complex With Pyrrolidinmethanamine
pdb|1XL5|A Chain A, Hiv-1 Protease In Complex With Amidhyroxysulfone
pdb|1XL5|B Chain B, Hiv-1 Protease In Complex With Amidhyroxysulfone
pdb|1SP5|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With A
Product Of Autoproteolysis
pdb|1SP5|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With A
Product Of Autoproteolysis
pdb|2A4F|A Chain A, Synthesis And Activity Of N-Axyl Azacyclic Urea Hiv-1
Protease Inhibitors With High Potency Against Multiple
Drug Resistant Viral Strains.
pdb|2A4F|B Chain B, Synthesis And Activity Of N-Axyl Azacyclic Urea Hiv-1
Protease Inhibitors With High Potency Against Multiple
Drug Resistant Viral Strains.
pdb|2BB9|A Chain A, Structure Of Hiv1 Protease And Akc4p_133a Complex.
pdb|2BB9|B Chain B, Structure Of Hiv1 Protease And Akc4p_133a Complex.
pdb|2BBB|A Chain A, Structure Of Hiv1 Protease And Hh1_173_3a Complex.
pdb|2BBB|B Chain B, Structure Of Hiv1 Protease And Hh1_173_3a Complex.
pdb|2BQV|A Chain A, Hiv-1 Protease In Complex With Inhibitor Aha455
pdb|2BQV|B Chain B, Hiv-1 Protease In Complex With Inhibitor Aha455
pdb|2AQU|A Chain A, Structure Of Hiv-1 Protease Bound To Atazanavir
pdb|2AQU|B Chain B, Structure Of Hiv-1 Protease Bound To Atazanavir
pdb|2CEJ|A Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|2CEJ|B Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|2CEM|A Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|2CEM|B Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|2CEN|A Chain A, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|2CEN|B Chain B, P1' Extended Hiv-1 Protease Inhibitors Encompassing A
Tertiary Alcohol In The Transition-State Mimicking
Scaffold
pdb|1HHP|A Chain A, The Three-Dimensional Structure Of The Aspartyl Protease
From The Hiv- 1 Isolate Bru
pdb|1UPJ|A Chain A, Hiv-1 Protease Complex With U095438
[3-[1-(4-Bromophenyl) Isobutyl]-4- Hydroxycoumarin
pdb|3PHV|A Chain A, X-Ray Analysis Of Hiv-1 Proteinase At 2.7 Angstroms
Resolution Confirms Structural Homology Among
Retroviral Enzymes
pdb|2PQZ|A Chain A, Hiv-1 Protease In Complex With A Pyrrolidine-Based
Inhibitor
pdb|2PQZ|B Chain B, Hiv-1 Protease In Complex With A Pyrrolidine-Based
Inhibitor
pdb|2PWC|A Chain A, Hiv-1 Protease In Complex With A Amino Decorated
Pyrrolidine-Based Inhibitor
pdb|2PWC|B Chain B, Hiv-1 Protease In Complex With A Amino Decorated
Pyrrolidine-Based Inhibitor
pdb|2PWR|A Chain A, Hiv-1 Protease In Complex With A Carbamoyl Decorated
Pyrrolidine-Based Inhibitor
pdb|2PWR|B Chain B, Hiv-1 Protease In Complex With A Carbamoyl Decorated
Pyrrolidine-Based Inhibitor
pdb|2QNN|A Chain A, Hiv-1 Protease In Complex With A Multiple Decorated
Pyrrolidine-Based Inhibitor
pdb|2QNN|B Chain B, Hiv-1 Protease In Complex With A Multiple Decorated
Pyrrolidine-Based Inhibitor
pdb|2QNP|A Chain A, Hiv-1 Protease In Complex With A Iodo Decorated
Pyrrolidine- Based Inhibitor
pdb|2QNP|B Chain B, Hiv-1 Protease In Complex With A Iodo Decorated
Pyrrolidine- Based Inhibitor
pdb|2QNQ|A Chain A, Hiv-1 Protease In Complex With A Chloro Decorated
Pyrrolidine-Based Inhibitor
pdb|2QNQ|B Chain B, Hiv-1 Protease In Complex With A Chloro Decorated
Pyrrolidine-Based Inhibitor
pdb|2UXZ|A Chain A, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
Tertiary-Alcohol-Containing Transition-State Mimic
pdb|2UXZ|B Chain B, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
Tertiary-Alcohol-Containing Transition-State Mimic
pdb|2UY0|A Chain A, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
Tertiary-Alcohol-Containing Transition-State Mimic
pdb|2UY0|B Chain B, Two-Carbon-Elongated Hiv-1 Protease Inhibitors With A
Tertiary-Alcohol-Containing Transition-State Mimic
pdb|3BGB|A Chain A, Hiv-1 Protease In Complex With A Isobutyl Decorated
Oligoamine
pdb|3BGB|B Chain B, Hiv-1 Protease In Complex With A Isobutyl Decorated
Oligoamine
pdb|3BGC|A Chain A, Hiv-1 Protease In Complex With A Benzyl Decorated
Oligoamine
pdb|3BGC|B Chain B, Hiv-1 Protease In Complex With A Benzyl Decorated
Oligoamine
pdb|3BHE|A Chain A, Hiv-1 Protease In Complex With A Three Armed Pyrrolidine
Derivative
pdb|3BHE|B Chain B, Hiv-1 Protease In Complex With A Three Armed Pyrrolidine
Derivative
pdb|2ZGA|A Chain A, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
Pyrrolidine Based Inhibitor (Hexagonal Space Group)
pdb|3CKT|A Chain A, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
Pyrrolidine Based Inhibitor (Orthorombic Space Group)
pdb|3CKT|B Chain B, Hiv-1 Protease In Complex With A Dimethylallyl Decorated
Pyrrolidine Based Inhibitor (Orthorombic Space Group)
pdb|3GGA|G Chain G, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGA|H Chain H, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGA|A Chain A, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGA|B Chain B, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGA|C Chain C, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGA|D Chain D, Hiv Protease Inhibitors With Pseudo-Symmetric Cores
pdb|3GGV|B Chain B, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|A Chain A, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|C Chain C, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|D Chain D, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|E Chain E, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|F Chain F, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|G Chain G, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|H Chain H, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGV|I Chain I, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|A Chain A, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|B Chain B, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|C Chain C, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|D Chain D, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|E Chain E, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|F Chain F, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|G Chain G, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|3GGX|H Chain H, Hiv Protease, Pseudo-Symmetric Inhibitors
pdb|2WKZ|A Chain A, Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol
In The Transition-State Mimic With Improved Cell-Based
Antiviral Activity
pdb|2WKZ|B Chain B, Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol
In The Transition-State Mimic With Improved Cell-Based
Antiviral Activity
pdb|3PSU|A Chain A, Hiv-1 Protease In Complex With An Isobutyl Decorated
Oligoamine (Symmetric Binding Mode)
pdb|4FE6|A Chain A, Crystal Structure Of Hiv-1 Protease In Complex With An
Enamino- Oxindole Inhibitor
pdb|3T11|A Chain A, Dimeric Inhibitor Of Hiv-1 Protease.
pdb|3T11|B Chain B, Dimeric Inhibitor Of Hiv-1 Protease.
pdb|1OHR|A Chain A, Viracept (R) (Nelfinavir Mesylate, Ag1343): A Potent
Orally Bioavailable Inhibitor Of Hiv-1 Protease
pdb|1OHR|B Chain B, Viracept (R) (Nelfinavir Mesylate, Ag1343): A Potent
Orally Bioavailable Inhibitor Of Hiv-1 Protease
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1AAQ|A Chain A, Hydroxyethylene Isostere Inhibitors Of Human
Immunodeficiency Virus-1 Protease: Structure-Activity
Analysis Using Enzyme Kinetics, X-Ray Crystallography,
And Infected T-Cell Assays
pdb|1AAQ|B Chain B, Hydroxyethylene Isostere Inhibitors Of Human
Immunodeficiency Virus-1 Protease: Structure-Activity
Analysis Using Enzyme Kinetics, X-Ray Crystallography,
And Infected T-Cell Assays
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1G6L|A Chain A, 1.9a Crystal Structure Of Tethered Hiv-1 Protease
Length = 203
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 121 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 163
>pdb|1BV9|A Chain A, Hiv-1 Protease (I84v) Complexed With Xv638 Of Dupont
Pharmaceuticals
pdb|1BV9|B Chain B, Hiv-1 Protease (I84v) Complexed With Xv638 Of Dupont
Pharmaceuticals
pdb|1MER|A Chain A, Hiv-1 Mutant (I84v) Protease Complexed With Dmp450
pdb|1MER|B Chain B, Hiv-1 Mutant (I84v) Protease Complexed With Dmp450
pdb|1MES|A Chain A, Hiv-1 Mutant (I84v) Protease Complexed With Dmp323
pdb|1MES|B Chain B, Hiv-1 Mutant (I84v) Protease Complexed With Dmp323
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HEF|E Chain E, The Crystal Structures At 2.2 Angstroms Resolution Of
Hydroxyethylene- Based Inhibitors Bound To Human
Immunodeficiency Virus Type 1 Protease Show That The
Inhibitors Are Present In Two Distinct Orientations
pdb|1HEG|E Chain E, The Crystal Structures At 2.2 Angstroms Resolution Of
Hydroxyethylene- Based Inhibitors Bound To Human
Immunodeficiency Virus Type 1 Protease Show That The
Inhibitors Are Present In Two Distinct Orientations
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEENSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|5HVP|A Chain A, Crystallographic Analysis Of A Complex Between Human
Immunodeficiency Virus Type 1 Protease And
Acetyl-Pepstatin At 2.0-Angstroms Resolution
pdb|5HVP|B Chain B, Crystallographic Analysis Of A Complex Between Human
Immunodeficiency Virus Type 1 Protease And
Acetyl-Pepstatin At 2.0-Angstroms Resolution
pdb|9HVP|A Chain A, Design, Activity And 2.8 Angstroms Crystal Structure Of
A C2 Symmetric Inhibitor Complexed To Hiv-1 Protease
pdb|9HVP|B Chain B, Design, Activity And 2.8 Angstroms Crystal Structure Of
A C2 Symmetric Inhibitor Complexed To Hiv-1 Protease
pdb|4PHV|A Chain A, X-Ray Crystal Structure Of The Hiv Protease Complex With
L- 700,417, An Inhibitor With Pseudo C2 Symmetry
pdb|4PHV|B Chain B, X-Ray Crystal Structure Of The Hiv Protease Complex With
L- 700,417, An Inhibitor With Pseudo C2 Symmetry
pdb|1SBG|A Chain A, An Orally-Bioavailable Hiv-1 Protease Inhibitor
Containing An Imidazole-Derived Peptide Bond
Replacement. Crystallographic And Pharmacokinetic
Analysis
pdb|1SBG|B Chain B, An Orally-Bioavailable Hiv-1 Protease Inhibitor
Containing An Imidazole-Derived Peptide Bond
Replacement. Crystallographic And Pharmacokinetic
Analysis
pdb|1PRO|A Chain A, Hiv-1 Protease Dimer Complexed With A-98881
pdb|1PRO|B Chain B, Hiv-1 Protease Dimer Complexed With A-98881
pdb|1A8G|A Chain A, Hiv-1 Protease In Complex With Sdz283-910
pdb|1A8G|B Chain B, Hiv-1 Protease In Complex With Sdz283-910
pdb|1VIK|A Chain A, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
Orthorhombic Form
pdb|1VIK|B Chain B, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
Orthorhombic Form
pdb|1VIJ|A Chain A, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
Hexagonal Form
pdb|1VIJ|B Chain B, Hiv-1 Protease Complexed With The Inhibitor HoeBAY 793
Hexagonal Form
pdb|1EBY|A Chain A, Hiv-1 Protease In Complex With The Inhibitor Bea369
pdb|1EBY|B Chain B, Hiv-1 Protease In Complex With The Inhibitor Bea369
pdb|1IZH|A Chain A, Inhibitor Of Hiv Protease With Unusual Binding Mode
Potently Inhibiting Multi-Resistant Protease Mutants
pdb|1IZH|B Chain B, Inhibitor Of Hiv Protease With Unusual Binding Mode
Potently Inhibiting Multi-Resistant Protease Mutants
pdb|2HVP|A Chain A, Three-Dimensional Structure Of Aspartyl Protease From
Human Immunodeficiency Virus Hiv-1
pdb|2QMP|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With
Pl-100
pdb|2QMP|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With
Pl-100
pdb|3M9F|A Chain A, Hiv Protease Complexed With Compound 10b
pdb|3M9F|B Chain B, Hiv Protease Complexed With Compound 10b
pdb|3S85|A Chain A, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|B Chain B, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|C Chain C, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|D Chain D, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|E Chain E, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|F Chain F, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|G Chain G, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|H Chain H, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|I Chain I, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|J Chain J, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|K Chain K, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|3S85|L Chain L, Discovery Of New Hiv Protease Inhibitors With Potential
For Convenient Dosing And Reduced Side Effects:
A-790742 And A-792611.
pdb|1HXW|A Chain A, Hiv-1 Protease Dimer Complexed With A-84538
pdb|1HXW|B Chain B, Hiv-1 Protease Dimer Complexed With A-84538
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2R5P|A Chain A, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Indinavir
pdb|2R5P|B Chain B, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Indinavir
pdb|2R5P|C Chain C, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Indinavir
pdb|2R5P|D Chain D, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Indinavir
pdb|2R5Q|A Chain A, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Nelfinavir
pdb|2R5Q|B Chain B, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Nelfinavir
pdb|2R5Q|C Chain C, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Nelfinavir
pdb|2R5Q|D Chain D, Crystal Structure Analysis Of Hiv-1 Subtype C Protease
Complexed With Nelfinavir
pdb|2R8N|A Chain A, Structural Analysis Of The Unbound Form Of Hiv-1 Subtype
C Protease
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQIKEALLDTGADDTVIEEIALPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1GNM|A Chain A, Hiv-1 Protease Mutant With Val 82 Replaced By Asp (V82d)
Complexed With U89360e (Inhibitor)
pdb|1GNM|B Chain B, Hiv-1 Protease Mutant With Val 82 Replaced By Asp (V82d)
Complexed With U89360e (Inhibitor)
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2R38|A Chain A, I84v Hiv-1 Protease Mutant In Complex With A Carbamoyl
Decorated Pyrrolidine-Based Inhibitor
pdb|2R38|B Chain B, I84v Hiv-1 Protease Mutant In Complex With A Carbamoyl
Decorated Pyrrolidine-Based Inhibitor
pdb|2R3W|A Chain A, I84v Hiv-1 Protease In Complex With A Amino Decorated
Pyrrolidine-Based Inhibitor
pdb|2R3W|B Chain B, I84v Hiv-1 Protease In Complex With A Amino Decorated
Pyrrolidine-Based Inhibitor
pdb|3BC4|A Chain A, I84v Hiv-1 Protease In Complex With A Pyrrolidine
Diester
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2I4V|A Chain A, Hiv-1 Protease I84v, L90m With Tmc126
pdb|2I4V|B Chain B, Hiv-1 Protease I84v, L90m With Tmc126
pdb|2I4X|A Chain A, Hiv-1 Protease I84v, L90m With Gs-8374
pdb|2I4X|B Chain B, Hiv-1 Protease I84v, L90m With Gs-8374
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2I4U|A Chain A, Hiv-1 Protease With Tmc-126
pdb|2I4U|B Chain B, Hiv-1 Protease With Tmc-126
pdb|2I4W|A Chain A, Hiv-1 Protease Wt With Gs-8374
pdb|2I4W|B Chain B, Hiv-1 Protease Wt With Gs-8374
pdb|2I4D|A Chain A, Crystal Structure Of Wt Hiv-1 Protease With Gs-8373
pdb|2I4D|B Chain B, Crystal Structure Of Wt Hiv-1 Protease With Gs-8373
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HXB|A Chain A, Hiv-1 Proteinase Complexed With Ro 31-8959
pdb|1HXB|B Chain B, Hiv-1 Proteinase Complexed With Ro 31-8959
pdb|1ODW|A Chain A, Native Hiv-1 Proteinase
pdb|1ODW|B Chain B, Native Hiv-1 Proteinase
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3AID|B Chain B, A New Class Of Hiv-1 Protease Inhibitor: The
Crystallographic Structure, Inhibition And Chemical
Synthesis Of An Aminimide Peptide Isostere
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1W5Y|A Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
pdb|1W5Y|B Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
pdb|1W5V|A Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
pdb|1W5V|B Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
pdb|1W5W|A Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-symmetric Inhibitor
pdb|1W5W|B Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-symmetric Inhibitor
pdb|1W5X|A Chain A, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
pdb|1W5X|B Chain B, Hiv-1 Protease In Complex With Fluoro Substituted Diol-
Based C2-Symmetric Inhibitor
Length = 110
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 30 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 70
>pdb|2FLE|A Chain A, Structural Analysis Of Asymmetric Inhibitor Bound To The
Hiv-1 Protease V82a Mutant
pdb|2FLE|B Chain B, Structural Analysis Of Asymmetric Inhibitor Bound To The
Hiv-1 Protease V82a Mutant
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2AZ8|A Chain A, Hiv-1 Protease Nl4-3 In Complex With Inhibitor, Tl-3
pdb|2HB4|A Chain A, Structure Of Hiv Protease Nl4-3 In An Unliganded State
pdb|2PC0|A Chain A, Apo Wild-Type Hiv Protease In The Open Conformation
pdb|3KF0|A Chain A, Hiv Protease With Fragment 4d9 Bound
pdb|3KF0|B Chain B, Hiv Protease With Fragment 4d9 Bound
pdb|3KFN|A Chain A, Hiv Protease (Pr) With Inhibitor Tl-3 And Fragment Hit
4d9 By Soaking
pdb|3KFN|B Chain B, Hiv Protease (Pr) With Inhibitor Tl-3 And Fragment Hit
4d9 By Soaking
pdb|3KFP|A Chain A, Hiv Protease (Pr) With Inhibitor Tl-3 Bound, And Dmsos
In Exo Site
pdb|3KFR|A Chain A, Hiv Protease (Pr) Dimer With Inhibitor Tl-3 Bound And
Fragment 1f1 In The OutsideTOP OF FLAP
pdb|3KFR|B Chain B, Hiv Protease (Pr) Dimer With Inhibitor Tl-3 Bound And
Fragment 1f1 In The OutsideTOP OF FLAP
pdb|3KFS|A Chain A, Hiv Protease (pr) Dimer With Inhibitor Tl-3 Bound And
Fragment 2f4 In The Outside/top Of Flap
pdb|3KFS|B Chain B, Hiv Protease (pr) Dimer With Inhibitor Tl-3 Bound And
Fragment 2f4 In The Outside/top Of Flap
pdb|4E43|A Chain A, Hiv Protease (Pr) Dimer With Acetate In Exo Site And
Peptide In Active Site
pdb|4E43|B Chain B, Hiv Protease (Pr) Dimer With Acetate In Exo Site And
Peptide In Active Site
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HVH|A Chain A, Nonpeptide Cyclic Cyanoguanidines As Hiv Protease
Inhibitors
pdb|1HVH|B Chain B, Nonpeptide Cyclic Cyanoguanidines As Hiv Protease
Inhibitors
pdb|1QBU|A Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBU|B Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBT|A Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBT|B Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBR|A Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBR|B Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
Length = 99
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HVC|A Chain A, Crystal Structure Of A Tethered Dimer Of Hiv-1 Protease
Complexed With An Inhibitor
Length = 203
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 123 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 163
>pdb|2NPH|A Chain A, Crystal Structure Of Hiv1 Protease In Situ Product
Complex
pdb|2NPH|B Chain B, Crystal Structure Of Hiv1 Protease In Situ Product
Complex
pdb|3MIM|A Chain A, X-Ray Snapshot Of Hiv-1 Protease In Action: Observation
Of Tetrahedral Intermediate And Its Sihb With Catalytic
Aspartate
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3AID|A Chain A, A New Class Of Hiv-1 Protease Inhibitor: The
Crystallographic Structure, Inhibition And Chemical
Synthesis Of An Aminimide Peptide Isostere
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1LV1|A Chain A, Crystal Structure Analysis Of The Non-Active Site Mutant
Of Tethered Hiv-1 Protease To 2.1a Resolution
pdb|3DOX|A Chain A, X-Ray Structure Of Hiv-1 Protease In Situ Product
Complex
pdb|2WHH|A Chain A, Hiv-1 Protease Tethered Dimer Q-Product Complex Along
With Nucleophilic Water Molecule
Length = 203
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 121 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 163
>pdb|3MIM|B Chain B, X-Ray Snapshot Of Hiv-1 Protease In Action: Observation
Of Tetrahedral Intermediate And Its Sihb With Catalytic
Aspartate
Length = 104
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1ZBG|A Chain A, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
(A71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor Boc-Phe-
Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
pdb|1ZBG|B Chain B, Crystal Structure Of A Complex Of Mutant Hiv-1 Protease
(A71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor Boc-Phe-
Psi[r-Ch(Oh)ch2nh]-Phe-Glu-Phe-Nh2
pdb|1ZPK|A Chain A, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (a71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor Boc-phe-
Psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2
pdb|1ZPK|B Chain B, Crystal Structure Of The Complex Of Mutant Hiv-1
Protease (a71v, V82t, I84v) With A Hydroxyethylamine
Peptidomimetic Inhibitor Boc-phe-
Psi[r-ch(oh)ch2nh]-phe-glu-phe-nh2
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1D4S|A Chain A, Hiv-1 Protease V82fI84V DOUBLE MUTANTTIPRANAVIR COMPLEX
pdb|1D4S|B Chain B, Hiv-1 Protease V82fI84V DOUBLE MUTANTTIPRANAVIR COMPLEX
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3IXO|A Chain A, Crystal Structure Of Uncomplexed Hiv_1 Protease Subtype
A
pdb|3IXO|B Chain B, Crystal Structure Of Uncomplexed Hiv_1 Protease Subtype
A
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 16 VIADVINNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
V + ++EA + G D+ VL+E L W+ K+ G G+G K K++
Sbjct: 11 VTVKIGGQLREALLDTGADDTVLEEINLPGKWKPKMIG-GIGGFIKVKQY 59
>pdb|1HIV|A Chain A, Crystal Structure Of A Complex Of Hiv-1 Protease With A
Dihydroethylene-Containing Inhibitor: Comparisons With
Molecular Modeling
pdb|1HIV|B Chain B, Crystal Structure Of A Complex Of Hiv-1 Protease With A
Dihydroethylene-Containing Inhibitor: Comparisons With
Molecular Modeling
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1ZSF|A Chain A, Crystal Structure Of Complex Of A Hydroxyethylamine
Inhibitor With Hiv-1 Protease At 2.0a Resolution
pdb|1ZSF|B Chain B, Crystal Structure Of Complex Of A Hydroxyethylamine
Inhibitor With Hiv-1 Protease At 2.0a Resolution
pdb|1ZSR|A Chain A, Crystal Structure Of Wild Type Hiv-1 Protease (Bru
Isolate) With A Hydroxyethylamine Peptidomimetic
Inhibitor Boc-Phe-Psi[s-Ch(Oh) Ch2nh]-Phe-Glu-Phe-Nh2
pdb|1ZSR|B Chain B, Crystal Structure Of Wild Type Hiv-1 Protease (Bru
Isolate) With A Hydroxyethylamine Peptidomimetic
Inhibitor Boc-Phe-Psi[s-Ch(Oh) Ch2nh]-Phe-Glu-Phe-Nh2
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1BV7|A Chain A, Counteracting Hiv-1 Protease Drug Resistance: Structural
Analysis Of Mutant Proteases Complexed With Xv638 And
Sd146, Cyclic Urea Amides With Broad Specificities
pdb|1BV7|B Chain B, Counteracting Hiv-1 Protease Drug Resistance: Structural
Analysis Of Mutant Proteases Complexed With Xv638 And
Sd146, Cyclic Urea Amides With Broad Specificities
pdb|1MET|A Chain A, Hiv-1 Mutant (V82f) Protease Complexed With Dmp323
pdb|1MET|B Chain B, Hiv-1 Mutant (V82f) Protease Complexed With Dmp323
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2P3B|B Chain B, Crystal Structure Of The Subtype B Wild Type Hiv
Protease Complexed With Tl-3 Inhibitor
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1DIF|A Chain A, Hiv-1 Protease In Complex With A Difluoroketone
Containing Inhibitor A79285
pdb|1DIF|B Chain B, Hiv-1 Protease In Complex With A Difluoroketone
Containing Inhibitor A79285
pdb|1HVI|A Chain A, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVI|B Chain B, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVJ|A Chain A, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVJ|B Chain B, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVK|A Chain A, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVK|B Chain B, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVL|A Chain A, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
pdb|1HVL|B Chain B, Influence Of Stereochemistry On Activity And Binding
Modes For C2 Symmetry-Based Diol Inhibitors Of Hiv-1
Protease
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1HVS|A Chain A, Structural Basis Of Drug Resistance For The V82a Mutant
Of Hiv-1 Protease: Backbone Flexibility And Subsite
Repacking
pdb|1HVS|B Chain B, Structural Basis Of Drug Resistance For The V82a Mutant
Of Hiv-1 Protease: Backbone Flexibility And Subsite
Repacking
Length = 99
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|4HVP|A Chain A, Structure Of Complex Of Synthetic Hiv-1 Protease With A
Stubtrate- Based Inhibitor At 2.3 Angstroms Resolution
pdb|4HVP|B Chain B, Structure Of Complex Of Synthetic Hiv-1 Protease With A
Stubtrate- Based Inhibitor At 2.3 Angstroms Resolution
pdb|7HVP|A Chain A, X-Ray Crystallographic Structure Of A Complex Between A
Synthetic Protease Of Human Immunodeficiency Virus 1
And A Substrate-Based Hydroxyethylamine Inhibitor
pdb|7HVP|B Chain B, X-Ray Crystallographic Structure Of A Complex Between A
Synthetic Protease Of Human Immunodeficiency Virus 1
And A Substrate-Based Hydroxyethylamine Inhibitor
pdb|8HVP|A Chain A, Structure At 2.5-Angstroms Resolution Of Chemically
Synthesized Human Immunodeficiency Virus Type 1
Protease Complexed With A Hydroxyethylene-Based
Inhibitor
pdb|8HVP|B Chain B, Structure At 2.5-Angstroms Resolution Of Chemically
Synthesized Human Immunodeficiency Virus Type 1
Protease Complexed With A Hydroxyethylene-Based
Inhibitor
pdb|1CPI|A Chain A, Regioselective Structural And Functional Mimicry Of
Peptides. Design Of Hydrolytically Stable Cyclic
Peptidomimetic Inhibitors Of Hiv-1 Protease
pdb|1CPI|B Chain B, Regioselective Structural And Functional Mimicry Of
Peptides. Design Of Hydrolytically Stable Cyclic
Peptidomimetic Inhibitors Of Hiv-1 Protease
pdb|1B6J|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 1
pdb|1B6J|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 1
pdb|3HVP|A Chain A, Conserved Folding In Retroviral Proteases. Crystal
Structure Of A Synthetic Hiv-1 Protease
Length = 99
Score = 27.7 bits (60), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1BWA|A Chain A, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
Xv638 Of Dupont Pharmaceuticals
pdb|1BWA|B Chain B, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
Xv638 Of Dupont Pharmaceuticals
pdb|1MEU|A Chain A, Hiv-1 Mutant (V82f, I84v) Protease Complexed With Dmp323
pdb|1MEU|B Chain B, Hiv-1 Mutant (V82f, I84v) Protease Complexed With Dmp323
pdb|1BWB|A Chain A, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
SD146 OF Dupont Pharmaceuticals
pdb|1BWB|B Chain B, Hiv-1 Protease (V82fI84V) DOUBLE MUTANT COMPLEXED WITH
SD146 OF Dupont Pharmaceuticals
Length = 99
Score = 27.7 bits (60), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2HS2|A Chain A, Crystal Structure Of M46l Mutant Of Hiv-1 Protease
Complexed With Tmc114 (Darunavir)
pdb|2HS2|B Chain B, Crystal Structure Of M46l Mutant Of Hiv-1 Protease
Complexed With Tmc114 (Darunavir)
Length = 99
Score = 27.7 bits (60), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ KL G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKLIG-GIGGFIKVRQY 59
>pdb|1HVR|A Chain A, Rational Design Of Potent, Bioavailable, Nonpeptide
Cyclic Ureas As Hiv Protease Inhibitors
pdb|1HVR|B Chain B, Rational Design Of Potent, Bioavailable, Nonpeptide
Cyclic Ureas As Hiv Protease Inhibitors
pdb|1QBS|A Chain A, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
pdb|1QBS|B Chain B, Hiv-1 Protease Inhibitors Wiih Low Nanomolar Potency
Length = 99
Score = 27.7 bits (60), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2P3C|A Chain A, Crystal Structure Of The Subtype F Wild Type Hiv
Protease Complexed With Tl-3 Inhibitor
pdb|2P3C|B Chain B, Crystal Structure Of The Subtype F Wild Type Hiv
Protease Complexed With Tl-3 Inhibitor
Length = 99
Score = 27.7 bits (60), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 16 VIADVINNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
V V +KEA + G D+ VL++ L W+ K+ G G+G K K++
Sbjct: 11 VTIKVGGQLKEALLDTGADDTVLEDIALPGKWKPKMIG-GIGGFIKVKQY 59
>pdb|1BVG|A Chain A, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr Minimized
Average Structure
pdb|1BVG|B Chain B, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr Minimized
Average Structure
pdb|1BVE|A Chain A, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr, 28
Structures
pdb|1BVE|B Chain B, Hiv-1 Protease-Dmp323 Complex In Solution, Nmr, 28
Structures
pdb|1HWR|A Chain A, Molecular Recognition Of Cyclic Urea Hiv Protease
Inhibitors
pdb|1HWR|B Chain B, Molecular Recognition Of Cyclic Urea Hiv Protease
Inhibitors
Length = 99
Score = 27.7 bits (60), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1DMP|A Chain A, Structure Of Hiv-1 Protease Complex
pdb|1DMP|B Chain B, Structure Of Hiv-1 Protease Complex
Length = 99
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|4DQH|A Chain A, Crystal Structure Of (R14cE65C) HIV-1 Protease In
Complex With Drv
pdb|4DQH|B Chain B, Crystal Structure Of (R14cE65C) HIV-1 Protease In
Complex With Drv
Length = 99
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2AVQ|A Chain A, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVQ|B Chain B, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVS|A Chain A, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVS|B Chain B, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2F8G|A Chain A, Hiv-1 Protease Mutant I50v Complexed With Inhibitor
Tmc114
pdb|2F8G|B Chain B, Hiv-1 Protease Mutant I50v Complexed With Inhibitor
Tmc114
pdb|2QD6|A Chain A, Hiv-1 Protease Mutant I50v With Potent Antiviral
Inhibitor Grl-98065
pdb|2QD6|B Chain B, Hiv-1 Protease Mutant I50v With Potent Antiviral
Inhibitor Grl-98065
pdb|3CYX|A Chain A, Crystal Structure Of Hiv-1 Mutant I50v And Inhibitor
Saquinavira
pdb|3CYX|B Chain B, Crystal Structure Of Hiv-1 Mutant I50v And Inhibitor
Saquinavira
pdb|3NU5|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant I50v With
Antiviral Drug Amprenavir
pdb|3NU5|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant I50v With
Antiviral Drug Amprenavir
Length = 99
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G GVG K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GVGGFIKVRQY 59
>pdb|1MT7|A Chain A, Viability Of A Drug-resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MT7|B Chain B, Viability Of A Drug-resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MT8|A Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MT8|B Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MT9|A Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MT9|B Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1N49|A Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
Structural Insights For Better Anti-Viral Therapy
pdb|1N49|B Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
Structural Insights For Better Anti-Viral Therapy
pdb|1N49|C Chain C, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
Structural Insights For Better Anti-Viral Therapy
pdb|1N49|D Chain D, Viability Of A Drug-Resistant Hiv-1 Protease Variant:
Structural Insights For Better Anti-Viral Therapy
pdb|1TSQ|A Chain A, Crystal Structure Of Ap2v Substrate Variant Of Nc-P1
Decamer Peptide In Complex With V82aD25N HIV-1 Protease
Mutant
pdb|1TSQ|B Chain B, Crystal Structure Of Ap2v Substrate Variant Of Nc-P1
Decamer Peptide In Complex With V82aD25N HIV-1 Protease
Mutant
pdb|2FNT|A Chain A, Crystal Structure Of A Drug-Resistant (V82a) Inactive
(D25n) Hiv-1 Protease Complexed With Ap2v Variant Of
Hiv-1 Nc-P1 Substrate.
pdb|2FNT|B Chain B, Crystal Structure Of A Drug-Resistant (V82a) Inactive
(D25n) Hiv-1 Protease Complexed With Ap2v Variant Of
Hiv-1 Nc-P1 Substrate
Length = 99
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2NXD|A Chain A, Structure Of Hiv-1 Protease D25n Complexed With Rt-Rh
Analogue Peptide Gly-Ala-Asp-Ile-PheTyr-Leu-Asp-Gly-Ala
pdb|2NXD|B Chain B, Structure Of Hiv-1 Protease D25n Complexed With Rt-Rh
Analogue Peptide Gly-Ala-Asp-Ile-PheTyr-Leu-Asp-Gly-Ala
pdb|2NXL|A Chain A, Structure Of Hiv-1 Protease D25n Complexed With The
Rt-Rh Analogue Peptide
Gly-Ala-Glu-Val-PheTyr-Val-Asp-Gly-Ala
pdb|2NXL|B Chain B, Structure Of Hiv-1 Protease D25n Complexed With The
Rt-Rh Analogue Peptide
Gly-Ala-Glu-Val-PheTyr-Val-Asp-Gly-Ala
pdb|2NXM|A Chain A, Structure Of Hiv-1 Protease D25n Complexed With The
Rt-Rh Analogue Peptide
Gly-Ala-Gln-Thr-PheTyr-Val-Asp-Gly-Ala
pdb|2NXM|B Chain B, Structure Of Hiv-1 Protease D25n Complexed With The
Rt-Rh Analogue Peptide
Gly-Ala-Gln-Thr-PheTyr-Val-Asp-Gly-Ala
Length = 99
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2P3A|A Chain A, Crystal Structure Of The Multi-Drug Resistant Mutant
Subtype B Hiv Protease Complexed With Tl-3 Inhibitor
pdb|2P3A|B Chain B, Crystal Structure Of The Multi-Drug Resistant Mutant
Subtype B Hiv Protease Complexed With Tl-3 Inhibitor
Length = 99
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ ++ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMALPGKWKPRMIG-GIGGFVKVRQY 59
>pdb|1F7A|A Chain A, How Does A Symmetric Dimer Recognize An Asymmetric
Substrate? A Substrate Complex Of Hiv-1 Protease.
pdb|1F7A|B Chain B, How Does A Symmetric Dimer Recognize An Asymmetric
Substrate? A Substrate Complex Of Hiv-1 Protease.
pdb|1KJ4|A Chain A, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJ4|B Chain B, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJ4|C Chain C, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJ4|D Chain D, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJ7|A Chain A, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJ7|B Chain B, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJF|A Chain A, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJF|B Chain B, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJG|A Chain A, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJG|B Chain B, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJH|A Chain A, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1KJH|B Chain B, Substrate Shape Determines Specificity Of Recognition
Recognition For Hiv-1 Protease: Analysis Of Crystal
Structures Of Six Substrate Complexes
pdb|1TSU|A Chain A, Crystal Structure Of Decamer Ncp1 Substrate Peptide In
Complex With Wild-Type D25n Hiv-1 Protease Variant
pdb|1TSU|B Chain B, Crystal Structure Of Decamer Ncp1 Substrate Peptide In
Complex With Wild-Type D25n Hiv-1 Protease Variant
pdb|2FNS|A Chain A, Crystal Structure Of Wild-Type Inactive (D25n) Hiv-1
Protease Complexed With Wild-Type Hiv-1 Nc-P1
Substrate.
pdb|2FNS|B Chain B, Crystal Structure Of Wild-Type Inactive (D25n) Hiv-1
Protease Complexed With Wild-Type Hiv-1 Nc-P1 Substrate
Length = 99
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1MTB|A Chain A, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
pdb|1MTB|B Chain B, Viability Of A Drug-Resistant Hiv-1 Protease Mutant:
Structural Insights For Better Antiviral Therapy
Length = 99
Score = 27.3 bits (59), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1AXA|A Chain A, Active-Site Mobility In Human Immunodeficiency Virus
Type 1 Protease As Demonstrated By Crystal Structure Of
A28s Mutant
pdb|1AXA|B Chain B, Active-Site Mobility In Human Immunodeficiency Virus
Type 1 Protease As Demonstrated By Crystal Structure Of
A28s Mutant
Length = 99
Score = 27.3 bits (59), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGSDDTVLEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|4EP2|A Chain A, Crystal Structure Of Inactive Single Chain Wild-Type
Hiv-1 Protease In Complex With The Substrate Rt-Rh
pdb|4EP3|A Chain A, Crystal Structure Of Inactive Single Chain Wild-Type
Hiv-1 Protease In Complex With The Substrate Ca-P2
pdb|4EPJ|A Chain A, Crystal Structure Of Inactive Single Chain Wild-Type
Hiv-1 Protease In Complex With The Substrate P2-Nc
Length = 203
Score = 27.3 bits (59), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
Score = 27.3 bits (59), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 123 LKEALLNTGADDTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 163
>pdb|3D1Z|A Chain A, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
Darunavir
pdb|3D1Z|B Chain B, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
Darunavir
pdb|3D1X|A Chain A, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
Saquinavir
pdb|3D1X|B Chain B, Crystal Structure Of Hiv-1 Mutant I54m And Inhibitor
Saquinavir
pdb|3NU6|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant I54m With
Antiviral Drug Amprenavir
pdb|3NU6|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant I54m With
Antiviral Drug Amprenavir
Length = 99
Score = 27.3 bits (59), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFMKVRQY 59
>pdb|3LZV|A Chain A, Structure Of Nelfinavir-Resistant Hiv-1 Protease
(D30nN88D) IN Complex With Darunavir.
pdb|3LZV|B Chain B, Structure Of Nelfinavir-Resistant Hiv-1 Protease
(D30nN88D) IN Complex With Darunavir
Length = 99
Score = 27.3 bits (59), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADNTVLEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|3EM3|A Chain A, Crystal Structure Of Amprenavir (Apv) In Complex With A
Drug Resistant Hiv-1 Protease Variant (I50lA71V).
pdb|3EM3|B Chain B, Crystal Structure Of Amprenavir (Apv) In Complex With A
Drug Resistant Hiv-1 Protease Variant (I50lA71V)
Length = 99
Score = 26.9 bits (58), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GLGGFIKVRQY 59
>pdb|2Z54|A Chain A, The Influence Of I47a Mutation On Reduced Susceptibility
To The Protease Inhibitor Lopinavir
pdb|2Z54|B Chain B, The Influence Of I47a Mutation On Reduced Susceptibility
To The Protease Inhibitor Lopinavir
Length = 99
Score = 26.9 bits (58), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMAG-GIGGFVKVRQY 59
>pdb|3B80|A Chain A, Hiv-1 Protease Mutant I54v Complexed With Gem-Diol-Amine
Intermediate Nlltqi
pdb|3B80|B Chain B, Hiv-1 Protease Mutant I54v Complexed With Gem-Diol-Amine
Intermediate Nlltqi
pdb|3D1Y|A Chain A, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
Saquina
pdb|3D1Y|B Chain B, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
Saquina
pdb|3D20|A Chain A, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
Darunavia
pdb|3D20|B Chain B, Crystal Structure Of Hiv-1 Mutant I54v And Inhibitor
Darunavia
pdb|3NUJ|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant I54v With
Antiviral Drug Amprenavir
pdb|3NUJ|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant I54v With
Antiviral Drug Amprenavir
Length = 99
Score = 26.9 bits (58), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFVKVRQY 59
>pdb|3EM4|A Chain A, Crystal Structure Of Atazanavir (Atv) In Complex With
I50lA71V DRUG- Resistant Hiv-1 Protease
pdb|3EM4|B Chain B, Crystal Structure Of Atazanavir (Atv) In Complex With
I50lA71V DRUG- Resistant Hiv-1 Protease
pdb|3EM4|U Chain U, Crystal Structure Of Atazanavir (Atv) In Complex With
I50lA71V DRUG- Resistant Hiv-1 Protease
pdb|3EM4|V Chain V, Crystal Structure Of Atazanavir (Atv) In Complex With
I50lA71V DRUG- Resistant Hiv-1 Protease
pdb|3EM6|A Chain A, Crystal Structure Of I50lA71V MUTANT OF HIV-1 Protease
In Complex With Inhibitor Darunavir
pdb|3EM6|B Chain B, Crystal Structure Of I50lA71V MUTANT OF HIV-1 Protease
In Complex With Inhibitor Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMIG-GLGGFIKVRQY 59
>pdb|1TCX|A Chain A, Hiv Triple Mutant Protease Complexed With Inhibitor
Sb203386
pdb|1TCX|B Chain B, Hiv Triple Mutant Protease Complexed With Inhibitor
Sb203386
Length = 99
Score = 26.9 bits (58), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ +L+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTILEEMSLPGRWKPKMVG-GIGGFIKVRQY 59
>pdb|3QOZ|A Chain A, Structure Of Wild-Type Hiv Protease In Complex With
Darunavir
pdb|3QOZ|B Chain B, Structure Of Wild-Type Hiv Protease In Complex With
Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G + +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGRWKPKMIG-GIGGFIRVRQY 59
>pdb|3EKQ|A Chain A, Crystal Structure Of Inhibitor Saquinavir (Sqv) In
Complex With Multi- Drug Resistant Hiv-1 Protease
(L63pV82TI84V) (REFERRED TO AS ACT IN Paper)
pdb|3EKQ|B Chain B, Crystal Structure Of Inhibitor Saquinavir (Sqv) In
Complex With Multi- Drug Resistant Hiv-1 Protease
(L63pV82TI84V) (REFERRED TO AS ACT IN Paper)
Length = 99
Score = 26.9 bits (58), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ +G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMI-VGIGGFVKVRQY 59
>pdb|3LZU|B Chain B, Crystal Structure Of A Nelfinavir Resistant Hiv-1
Crf01_ae Protease Variant (N88s) In Complex With The
Protease Inhibitor Darunavir.
pdb|3LZU|A Chain A, Crystal Structure Of A Nelfinavir Resistant Hiv-1
Crf01_ae Protease Variant (N88s) In Complex With The
Protease Inhibitor Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 15/50 (30%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 16 VIADVINNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
V + +KEA + G D+ VL++ L W+ K+ G G+G K +++
Sbjct: 11 VTVKIGGQLKEALLDTGADDTVLEDINLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1HPO|A Chain A, Hiv-1 Protease Triple MutantU103265 COMPLEX
pdb|1HPO|B Chain B, Hiv-1 Protease Triple MutantU103265 COMPLEX
pdb|1A30|A Chain A, Hiv-1 Protease Complexed With A Tripeptide Inhibitor
pdb|1A30|B Chain B, Hiv-1 Protease Complexed With A Tripeptide Inhibitor
pdb|1A8K|A Chain A, Crystallographic Analysis Of Human Immunodeficiency
Virus 1 Protease With An Analog Of The Conserved Ca-P2
Substrate: Interactions With Frequently Occurring
Glutamic Acid Residue At P2' Position Of Substrates
pdb|1A8K|B Chain B, Crystallographic Analysis Of Human Immunodeficiency
Virus 1 Protease With An Analog Of The Conserved Ca-P2
Substrate: Interactions With Frequently Occurring
Glutamic Acid Residue At P2' Position Of Substrates
pdb|1A8K|D Chain D, Crystallographic Analysis Of Human Immunodeficiency
Virus 1 Protease With An Analog Of The Conserved Ca-P2
Substrate: Interactions With Frequently Occurring
Glutamic Acid Residue At P2' Position Of Substrates
pdb|1A8K|E Chain E, Crystallographic Analysis Of Human Immunodeficiency
Virus 1 Protease With An Analog Of The Conserved Ca-P2
Substrate: Interactions With Frequently Occurring
Glutamic Acid Residue At P2' Position Of Substrates
pdb|1D4Y|A Chain A, Hiv-1 Protease Triple MutantTIPRANAVIR COMPLEX
pdb|1D4Y|B Chain B, Hiv-1 Protease Triple MutantTIPRANAVIR COMPLEX
pdb|1MRW|A Chain A, Structure Of Hiv Protease (Mutant Q7k L33i L63i)
Complexed With Kni- 577
pdb|1MRW|B Chain B, Structure Of Hiv Protease (Mutant Q7k L33i L63i)
Complexed With Kni- 577
pdb|1MSM|A Chain A, The Hiv Protease (Mutant Q7k L33i L63i) Complexed With
Kni-764 (An Inhibitor)
pdb|1MSM|B Chain B, The Hiv Protease (Mutant Q7k L33i L63i) Complexed With
Kni-764 (An Inhibitor)
pdb|1ZTZ|A Chain A, Crystal Structure Of Hiv Protease- Metallacarborane
Complex
pdb|1ZTZ|B Chain B, Crystal Structure Of Hiv Protease- Metallacarborane
Complex
pdb|2PK5|A Chain A, Crystal Structure Of Hiv-1 Protease (q7k, L33i, L63i )
In Complex With Kni-10075
pdb|2PK5|B Chain B, Crystal Structure Of Hiv-1 Protease (q7k, L33i, L63i )
In Complex With Kni-10075
pdb|2PK6|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10033
pdb|2PK6|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10033
pdb|3I8W|A Chain A, Crystal Structure Of A Metallacarborane Inhibitor Bound
To Hiv Protease
pdb|3KDB|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10006
pdb|3KDB|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10006
pdb|3KDD|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10265
pdb|3KDD|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10265
pdb|3KDC|A Chain A, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10074
pdb|3KDC|B Chain B, Crystal Structure Of Hiv-1 Protease (Q7k, L33i, L63i) In
Complex With Kni-10074
pdb|3NLS|A Chain A, Crystal Structure Of Hiv-1 Protease In Complex With
Kni-10772
pdb|3NLS|B Chain B, Crystal Structure Of Hiv-1 Protease In Complex With
Kni-10772
pdb|3TH9|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant Q7k V32i L63i
With A Cyclic Sulfonamide Inhibitor
pdb|3TH9|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant Q7k V32i L63i
With A Cyclic Sulfonamide Inhibitor
pdb|3QBF|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QBF|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QIH|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QIH|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QN8|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QN8|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QP0|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QP0|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Novel Inhibitor
pdb|3QPJ|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QPJ|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRM|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRM|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRO|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRO|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRS|A Chain A, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
pdb|3QRS|B Chain B, Hiv-1 Protease (Mutant Q7k L33i L63i) In Complex With A
Three-Armed Pyrrolidine-Based Inhibitor
Length = 99
Score = 26.9 bits (58), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3EKP|A Chain A, Crystal Structure Of The Inhibitor Amprenavir (Apv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A)REFER: FLAP+ IN CITATION
pdb|3EKP|B Chain B, Crystal Structure Of The Inhibitor Amprenavir (Apv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A)REFER: FLAP+ IN CITATION
pdb|3EKP|C Chain C, Crystal Structure Of The Inhibitor Amprenavir (Apv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A)REFER: FLAP+ IN CITATION
pdb|3EKP|D Chain D, Crystal Structure Of The Inhibitor Amprenavir (Apv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A)REFER: FLAP+ IN CITATION
pdb|3EKT|A Chain A, Crystal Structure Of The Inhibitor Darunavir (Drv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10fG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION.)
pdb|3EKT|B Chain B, Crystal Structure Of The Inhibitor Darunavir (Drv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10fG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION.)
pdb|3EKT|C Chain C, Crystal Structure Of The Inhibitor Darunavir (Drv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10fG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION.)
pdb|3EKT|D Chain D, Crystal Structure Of The Inhibitor Darunavir (Drv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10fG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION.)
pdb|3EKW|A Chain A, Crystal Structure Of The Inhibitor Atazanavir (Atv) In
Complex With A Multi-Drug Resistance Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A) REFER: FLAP+ IN
CITATION.
pdb|3EKW|B Chain B, Crystal Structure Of The Inhibitor Atazanavir (Atv) In
Complex With A Multi-Drug Resistance Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A) REFER: FLAP+ IN
CITATION.
pdb|3EL0|A Chain A, Crystal Structure Of The Inhibitor Nelfinavir (Nfv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION)
pdb|3EL0|B Chain B, Crystal Structure Of The Inhibitor Nelfinavir (Nfv) In
Complex With A Multi-Drug Resistant Hiv-1 Protease
Variant (L10iG48VI54VV64IV82A) (REFER: FLAP+ IN
CITATION)
Length = 99
Score = 26.9 bits (58), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ +G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEEMNLPGKWKPKMI-VGIGGFVKVRQY 59
>pdb|2AVV|A Chain A, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVV|B Chain B, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVV|D Chain D, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVV|E Chain E, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3JW2|A Chain A, Hiv-1 Protease Mutant G86s With Darunavir
pdb|3JW2|B Chain B, Hiv-1 Protease Mutant G86s With Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1K2B|A Chain A, Combining Mutations In Hiv-1 Protease To Understand
Mechanisms Of Resistance
pdb|1K2B|B Chain B, Combining Mutations In Hiv-1 Protease To Understand
Mechanisms Of Resistance
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3JVW|A Chain A, Hiv-1 Protease Mutant G86a With Symmetric Inhibitor
Dmp323
pdb|3JVW|B Chain B, Hiv-1 Protease Mutant G86a With Symmetric Inhibitor
Dmp323
pdb|3JVY|A Chain A, Hiv-1 Protease Mutant G86a With Darunavir
pdb|3JVY|B Chain B, Hiv-1 Protease Mutant G86a With Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1DW6|C Chain C, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
pdb|1DW6|D Chain D, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
pdb|1FEJ|C Chain C, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1FEJ|D Chain D, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1SDU|A Chain A, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|1SDU|B Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|2F81|A Chain A, Hiv-1 Protease Mutant L90m Complexed With Inhibitor
Tmc114
pdb|2F81|B Chain B, Hiv-1 Protease Mutant L90m Complexed With Inhibitor
Tmc114
pdb|3NUO|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant L90m With
Antiviral Drug Amprenavir
pdb|3NUO|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant L90m With
Antiviral Drug Amprenavir
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3LZS|A Chain A, Crystal Structure Of Hiv-1 Crf01_ae Protease In Complex
With Darunavir
pdb|3LZS|B Chain B, Crystal Structure Of Hiv-1 Crf01_ae Protease In Complex
With Darunavir
Length = 99
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL++ L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVLEDINLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|1Q9P|A Chain A, Solution Structure Of The Mature Hiv-1 Protease Monomer
Length = 95
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1MRX|A Chain A, Structure Of Hiv Protease (Mutant Q7k L33i L63i V82f
I84v ) Complexed With Kni-577
pdb|1MRX|B Chain B, Structure Of Hiv Protease (Mutant Q7k L33i L63i V82f
I84v ) Complexed With Kni-577
pdb|1MSN|A Chain A, The Hiv Protease (Mutant Q7k L33i L63i V82f I84v)
Complexed With Kni- 764 (An Inhibitor)
pdb|1MSN|B Chain B, The Hiv Protease (Mutant Q7k L33i L63i V82f I84v)
Complexed With Kni- 764 (An Inhibitor)
Length = 99
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|2QHC|A Chain A, The Influence Of I47a Mutation On Reduced Susceptibility
To The Protease Inhibitor Lopinavir
pdb|2QHC|B Chain B, The Influence Of I47a Mutation On Reduced Susceptibility
To The Protease Inhibitor Lopinavir
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMAG-GIGGFIKVRQY 59
>pdb|1SDV|A Chain A, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|1SDV|B Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|2AOE|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog Ca-P2
pdb|2AOE|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog Ca-P2
pdb|2AOF|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P1-P6
pdb|2AOF|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P1-P6
pdb|2AOG|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P2-Nc
pdb|2AOG|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P2-Nc
pdb|2AOH|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P6-Pr
pdb|2AOH|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Substrate Analog P6-Pr
pdb|2IDW|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Potent Non-Peptide Inhibitor (Uic-94017)
pdb|2IDW|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Potent Non-Peptide Inhibitor (Uic-94017)
pdb|2NMY|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Inhibitor Saquinavir
pdb|2NMY|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Inhibitor Saquinavir
pdb|2NMZ|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Inhibitor Saquinavir
pdb|2NMZ|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant V82a
With A Inhibitor Saquinavir
pdb|2QD7|A Chain A, Hiv-1 Protease Mutant V82a With Potent Antiviral
Inhibitor Grl-98065
pdb|2QD7|B Chain B, Hiv-1 Protease Mutant V82a With Potent Antiviral
Inhibitor Grl-98065
pdb|3VFA|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant V82a With
Novel P1'-Ligands Grl-02031
pdb|3VFA|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant V82a With
Novel P1'-Ligands Grl-02031
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1FG6|C Chain C, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1FG6|D Chain D, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1FG8|C Chain C, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1FG8|D Chain D, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|3VFB|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant N88d With
Novel P1'-Ligands Grl-02031
pdb|3VFB|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant N88d With
Novel P1'-Ligands Grl-02031
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1FGC|C Chain C, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1FGC|D Chain D, Structural Implications Of Drug Resistant Mutants Of
Hiv-1 Protease: High Resolution Crystal Structures Of
The Mutant ProteaseSUBSTRATE Analog Complexes
pdb|1SDT|A Chain A, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|1SDT|B Chain B, Crystal Structures Of Hiv Protease V82a And L90m Mutants
Reveal Changes In Indinavir Binding Site.
pdb|2AOD|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P2-Nc
pdb|2AOD|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P2-Nc
pdb|2AOI|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P1-P6
pdb|2AOI|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P1-P6
pdb|2AOJ|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P6-Pr
pdb|2AOJ|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
Substrate Analog P6-Pr
pdb|2HB3|A Chain A, Wild-Type Hiv-1 Protease In Complex With Potent
Inhibitor Grl06579
pdb|2HB3|B Chain B, Wild-Type Hiv-1 Protease In Complex With Potent
Inhibitor Grl06579
pdb|2IEN|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease With A
Potent Non-Peptide Inhibitor (Uic-94017)
pdb|2IEN|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease With A
Potent Non-Peptide Inhibitor (Uic-94017)
pdb|3B7V|A Chain A, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
Intermediate Nlltqi
pdb|3B7V|B Chain B, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
Intermediate Nlltqi
pdb|2Z4O|A Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-98065
pdb|2Z4O|B Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-98065
pdb|3DJK|A Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-0255a
pdb|3DJK|B Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-0255a
pdb|3FX5|A Chain A, Structure Of Hiv-1 Protease In Complex With Potent
Inhibitor Kni-272 Determined By High Resolution X-ray
Crystallography
pdb|3FX5|B Chain B, Structure Of Hiv-1 Protease In Complex With Potent
Inhibitor Kni-272 Determined By High Resolution X-ray
Crystallography
pdb|3DK1|A Chain A, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-0105a
pdb|3DK1|B Chain B, Wild Type Hiv-1 Protease With Potent Antiviral Inhibitor
Grl-0105a
pdb|3H5B|A Chain A, Crystal Structure Of Wild Type Hiv-1 Protease With Novel
P1'-Ligand Grl-02031
pdb|3H5B|B Chain B, Crystal Structure Of Wild Type Hiv-1 Protease With Novel
P1'-Ligand Grl-02031
pdb|3I6O|A Chain A, Crystal Structure Of Wild Type Hiv-1 Protease With
Macrocyclic Inhibitor Grl-0216a
pdb|3I6O|B Chain B, Crystal Structure Of Wild Type Hiv-1 Protease With
Macrocyclic Inhibitor Grl-0216a
pdb|3A2O|A Chain A, Crystal Structure Of Hiv-1 Protease Complexed With
Kni-1689
pdb|3A2O|B Chain B, Crystal Structure Of Hiv-1 Protease Complexed With
Kni-1689
pdb|3K4V|C Chain C, New Crystal Form Of Hiv-1 ProteaseSAQUINAVIR STRUCTURE
REVEALS Carbamylation Of N-Terminal Proline
pdb|3K4V|D Chain D, New Crystal Form Of Hiv-1 ProteaseSAQUINAVIR STRUCTURE
REVEALS Carbamylation Of N-Terminal Proline
pdb|3NU3|A Chain A, Wild Type Hiv-1 Protease With Antiviral Drug Amprenavir
pdb|3NU3|B Chain B, Wild Type Hiv-1 Protease With Antiviral Drug Amprenavir
pdb|3OK9|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease With New
Oxatricyclic Designed Inhibitor Grl-0519a
pdb|3OK9|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease With New
Oxatricyclic Designed Inhibitor Grl-0519a
pdb|3OXC|A Chain A, Wild Type Hiv-1 Protease With Antiviral Drug Saquinavir
pdb|3OXC|B Chain B, Wild Type Hiv-1 Protease With Antiviral Drug Saquinavir
pdb|3NDW|A Chain A, Hiv-1 Protease Saquinavir:ritonavir 1:15 Complex
Structure
pdb|3NDW|B Chain B, Hiv-1 Protease Saquinavir:ritonavir 1:15 Complex
Structure
pdb|3NDX|A Chain A, Hiv-1 Protease Saquinavir:ritonavir 1:50 Complex
Structure
pdb|3NDX|B Chain B, Hiv-1 Protease Saquinavir:ritonavir 1:50 Complex
Structure
pdb|3ST5|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease With
C3-Substituted Hexahydrocyclopentafuranyl Urethane As
P2-Ligand, Grl-0489a
pdb|3ST5|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease With
C3-Substituted Hexahydrocyclopentafuranyl Urethane As
P2-Ligand, Grl-0489a
pdb|3QAA|A Chain A, Hiv-1 Wild Type Protease With A Substituted
Bis-Tetrahydrofuran Inhibitor, Grl-044-10a
pdb|3QAA|B Chain B, Hiv-1 Wild Type Protease With A Substituted
Bis-Tetrahydrofuran Inhibitor, Grl-044-10a
pdb|4DFG|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease With
Cyclopentyltetrahydro- Furanyl Urethanes As P2-Ligand,
Grl-0249a
pdb|4DFG|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease With
Cyclopentyltetrahydro- Furanyl Urethanes As P2-Ligand,
Grl-0249a
pdb|3TOF|A Chain A, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 6 -
Orthorombic Crystal Form P212121)
pdb|3TOF|B Chain B, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 6 -
Orthorombic Crystal Form P212121)
pdb|3TOG|A Chain A, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Monoclinic Crystal Form P21)
pdb|3TOG|B Chain B, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Monoclinic Crystal Form P21)
pdb|3TOG|C Chain C, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Monoclinic Crystal Form P21)
pdb|3TOG|D Chain D, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Monoclinic Crystal Form P21)
pdb|3TOH|A Chain A, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Orthorombic Crystal Form P212121)
pdb|3TOH|B Chain B, Hiv-1 Protease - Epoxydic Inhibitor Complex (Ph 9 -
Orthorombic Crystal Form P212121)
pdb|4FL8|A Chain A, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
Intermediate
pdb|4FL8|B Chain B, Hiv-1 Protease Complexed With Gem-Diol-Amine Tetrahedral
Intermediate
pdb|2A1E|A Chain A, High Resolution Structure Of Hiv-1 Pr With Ts-126
pdb|2A1E|B Chain B, High Resolution Structure Of Hiv-1 Pr With Ts-126
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3K4V|A Chain A, New Crystal Form Of Hiv-1 ProteaseSAQUINAVIR STRUCTURE
REVEALS Carbamylation Of N-Terminal Proline
pdb|3K4V|B Chain B, New Crystal Form Of Hiv-1 ProteaseSAQUINAVIR STRUCTURE
REVEALS Carbamylation Of N-Terminal Proline
pdb|3NDT|A Chain A, Hiv-1 Protease Saquinavir:ritonavir 1:1 Complex
Structure
pdb|3NDT|B Chain B, Hiv-1 Protease Saquinavir:ritonavir 1:1 Complex
Structure
pdb|3NDT|C Chain C, Hiv-1 Protease Saquinavir:ritonavir 1:1 Complex
Structure
pdb|3NDT|D Chain D, Hiv-1 Protease Saquinavir:ritonavir 1:1 Complex
Structure
pdb|3NDU|A Chain A, Hiv-1 Protease Saquinavir:ritonavir 1:5 Complex
Structure
pdb|3NDU|B Chain B, Hiv-1 Protease Saquinavir:ritonavir 1:5 Complex
Structure
pdb|3NDU|C Chain C, Hiv-1 Protease Saquinavir:ritonavir 1:5 Complex
Structure
pdb|3NDU|D Chain D, Hiv-1 Protease Saquinavir:ritonavir 1:5 Complex
Structure
Length = 100
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 20 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 60
>pdb|2AOC|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Substrate Analog P2-Nc
pdb|2AOC|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Substrate Analog P2-Nc
pdb|2IEO|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Potent Non-peptide Inhibitor (uic-94017)
pdb|2IEO|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Potent Non-peptide Inhibitor (uic-94017)
pdb|2NNK|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Inhibitor Saquinavir
pdb|2NNK|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Inhibitor Saquinavir
pdb|2NNP|A Chain A, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Inhibitor Saquinavir
pdb|2NNP|B Chain B, Crystal Structure Analysis Of Hiv-1 Protease Mutant I84v
With A Inhibitor Saquinavir
pdb|2QD8|A Chain A, Hiv-1 Protease Mutant I84v With Potent Antiviral
Inhibitor Grl-98065
pdb|2QD8|B Chain B, Hiv-1 Protease Mutant I84v With Potent Antiviral
Inhibitor Grl-98065
pdb|3NU9|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant I84v With
Antiviral Drug Amprenavir
pdb|3NU9|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant I84v With
Antiviral Drug Amprenavir
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3TKG|A Chain A, Crystal Structure Of Hiv Model Protease
PrecursorSAQUINAVIR COMPLEX
pdb|3TKG|B Chain B, Crystal Structure Of Hiv Model Protease
PrecursorSAQUINAVIR COMPLEX
pdb|3TKG|C Chain C, Crystal Structure Of Hiv Model Protease
PrecursorSAQUINAVIR COMPLEX
pdb|3TKG|D Chain D, Crystal Structure Of Hiv Model Protease
PrecursorSAQUINAVIR COMPLEX
pdb|3TKW|A Chain A, Crystal Structure Of Hiv Protease Model
PrecursorDARUNAVIR COMPLEX
pdb|3TKW|B Chain B, Crystal Structure Of Hiv Protease Model
PrecursorDARUNAVIR COMPLEX
pdb|3TL9|A Chain A, Crystal Structure Of Hiv Protease Model
PrecursorSAQUINAVIR COMPLEX
pdb|3TL9|B Chain B, Crystal Structure Of Hiv Protease Model
PrecursorSAQUINAVIR COMPLEX
Length = 103
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 23 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 63
>pdb|4DQB|A Chain A, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Drv
pdb|4DQB|B Chain B, Crystal Structure Of Wild-Type Hiv-1 Protease In Complex
With Drv
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|3PWM|A Chain A, Hiv-1 Protease Mutant L76v With Darunavir
pdb|3PWM|B Chain B, Hiv-1 Protease Mutant L76v With Darunavir
pdb|3PWR|A Chain A, Hiv-1 Protease Mutant L76v Complexed With Saquinavir
pdb|3PWR|B Chain B, Hiv-1 Protease Mutant L76v Complexed With Saquinavir
pdb|3VF7|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant L76v With
Novel P1'-Ligands Grl-02031
pdb|3VF7|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant L76v With
Novel P1'-Ligands Grl-02031
Length = 99
Score = 26.9 bits (58), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1EBK|C Chain C, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
pdb|1EBK|D Chain D, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
pdb|1EBK|E Chain E, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
pdb|1EBK|F Chain F, Structural And Kinetic Analysis Of Drug Resistant
Mutants Of Hiv-1 Protease
Length = 99
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|1MTR|A Chain A, Hiv-1 Protease Complexed With A Cyclic Phe-Ile-Val
Peptidomimetic Inhibitor
pdb|1MTR|B Chain B, Hiv-1 Protease Complexed With A Cyclic Phe-Ile-Val
Peptidomimetic Inhibitor
pdb|1B6K|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 5
pdb|1B6K|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 5
pdb|1B6L|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 4
pdb|1B6L|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 4
pdb|1B6M|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 6
pdb|1B6M|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 6
pdb|1B6P|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 7
pdb|1B6P|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 7
pdb|1D4L|A Chain A, Hiv-1 Protease Complexed With A Macrocyclic
Peptidomimetic Inhibitor
pdb|1D4L|B Chain B, Hiv-1 Protease Complexed With A Macrocyclic
Peptidomimetic Inhibitor
pdb|1D4K|A Chain A, Hiv-1 Protease Complexed With A Macrocyclic
Peptidomimetic Inhibitor
pdb|1D4K|B Chain B, Hiv-1 Protease Complexed With A Macrocyclic
Peptidomimetic Inhibitor
pdb|1Z1H|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 3
pdb|1Z1H|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 3
pdb|1Z1R|A Chain A, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 2
pdb|1Z1R|B Chain B, Hiv-1 Protease Complexed With Macrocyclic Peptidomimetic
Inhibitor 2
pdb|3BXS|A Chain A, Crystal Structures Of Highly Constrained Substrate And
Hydrolysis Products Bound To Hiv-1 Protease.
Implications For Catalytic Mechanism
pdb|3BXS|B Chain B, Crystal Structures Of Highly Constrained Substrate And
Hydrolysis Products Bound To Hiv-1 Protease.
Implications For Catalytic Mechanism
Length = 99
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2FXE|A Chain A, X-Ray Crystal Structure Of Hiv-1 Protease Crm Mutant
Complexed With Atazanavir (Bms-232632)
pdb|2FXE|B Chain B, X-Ray Crystal Structure Of Hiv-1 Protease Crm Mutant
Complexed With Atazanavir (Bms-232632)
Length = 99
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMNLPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|3IZA|A Chain A, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|B Chain B, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|C Chain C, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|D Chain D, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|E Chain E, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|F Chain F, Structure Of An Apoptosome-Procaspase-9 Card Complex
pdb|3IZA|G Chain G, Structure Of An Apoptosome-Procaspase-9 Card Complex
Length = 1263
Score = 26.9 bits (58), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 14/52 (26%), Positives = 23/52 (44%), Gaps = 4/52 (7%)
Query: 62 EWMSKCYRSSNISGRPSLSGNLKARLVYQPCLTQPVELLSICAADHELQAIR 113
EW++K NI+ L VY C ++ + ++ C AD LQ +
Sbjct: 602 EWINK----KNITNLSRLVVRPHTDAVYHACFSEDGQRIASCGADKTLQVFK 649
>pdb|1FB7|A Chain A, Crystal Structure Of An In Vivo Hiv-1 Protease Mutant In
Complex With Saquinavir: Insights Into The Mechanisms
Of Drug Resistance
Length = 99
Score = 26.6 bits (57), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ +G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMI-VGIGGFIKVRQY 59
>pdb|2AVM|A Chain A, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVM|B Chain B, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVO|A Chain A, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
pdb|2AVO|B Chain B, Kinetics, Stability, And Structural Changes In High
Resolution Crystal Structures Of Hiv-1 Protease With
Drug Resistant Mutations L24i, I50v, And G73s
Length = 99
Score = 26.6 bits (57), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALIDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3RE4|A Chain A, Crystal Structure Of Archaeoglobus Fulgidus Rio1 Kinase
Bound To Toyocamycin.
pdb|3RE4|B Chain B, Crystal Structure Of Archaeoglobus Fulgidus Rio1 Kinase
Bound To Toyocamycin
Length = 258
Score = 26.6 bits (57), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 14/60 (23%), Positives = 30/60 (50%)
Query: 14 QAVIADVINNVKEAFQEEGVDEQVLQELKHIWEAKLFGIGVGKLSKRKEWMSKCYRSSNI 73
+ + DV+ NVK +QE + L E ++ K++ I +G+ + M++ Y ++
Sbjct: 173 EGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDKVYFIDMGQAVTLRHPMAESYLERDV 232
>pdb|4DQF|A Chain A, Crystal Structure Of (G16aL38A) HIV-1 Protease In
Complex With Drv
pdb|4DQF|B Chain B, Crystal Structure Of (G16aL38A) HIV-1 Protease In
Complex With Drv
Length = 99
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 13/46 (28%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 20 VINNVKEAFQEEGVDEQVLQELKHI--WEAKLFGIGVGKLSKRKEW 63
+ +KEA + G D+ V++E+ W+ K+ G G+G K +++
Sbjct: 15 IAGQLKEALLDTGADDTVIEEMNAPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|4DQC|A Chain A, Crystal Structure Of (G16cL38C) HIV-1 Protease In
Complex With Drv
pdb|4DQC|B Chain B, Crystal Structure Of (G16cL38C) HIV-1 Protease In
Complex With Drv
pdb|4DQE|A Chain A, Crystal Structure Of (G16cL38C) HIV-1 Protease In
Complex With Drv
pdb|4DQE|B Chain B, Crystal Structure Of (G16cL38C) HIV-1 Protease In
Complex With Drv
pdb|4DQG|A Chain A, Crystal Structure Of Apo(G16cL38C) HIV-1 Protease
pdb|4DQG|B Chain B, Crystal Structure Of Apo(G16cL38C) HIV-1 Protease
Length = 99
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 13/46 (28%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 20 VINNVKEAFQEEGVDEQVLQELK--HIWEAKLFGIGVGKLSKRKEW 63
+ +KEA + G D+ V++E+ W+ K+ G G+G K +++
Sbjct: 15 ICGQLKEALLDTGADDTVIEEMNCPGKWKPKMIG-GIGGFIKVRQY 59
>pdb|2ZYE|A Chain A, Structure Of Hiv-1 Protease In Complex With Potent
Inhibitor Kni-272 Determined By Neutron Crystallography
pdb|2ZYE|B Chain B, Structure Of Hiv-1 Protease In Complex With Potent
Inhibitor Kni-272 Determined By Neutron Crystallography
Length = 99
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|4FLG|B Chain B, Hiv-1 Protease Mutant I47v Complexed With Reaction
Intermediate
pdb|4FLG|A Chain A, Hiv-1 Protease Mutant I47v Complexed With Reaction
Intermediate
pdb|3VF5|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant I47v With
Novel P1'-Ligands Grl-02031
pdb|3VF5|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant I47v With
Novel P1'-Ligands Grl-02031
Length = 99
Score = 26.6 bits (57), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ V++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTVIEEMSLPGRWKPKMVG-GIGGFIKVRQY 59
>pdb|3N3I|A Chain A, Crystal Structure Of G48v/c95f Tethered Hiv-1
Protease/saquinavir Complex
Length = 203
Score = 26.6 bits (57), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ +G+G K +++
Sbjct: 17 GQLKEALLDTGADDTVLEEMSLPGRWKPKMI-VGIGGFIKVRQY 59
Score = 26.6 bits (57), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 22 NNVKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ VL+E L W+ K+ +G+G K +++
Sbjct: 121 GQLKEALLDTGADDTVLEEMSLPGRWKPKMI-VGIGGFIKVRQY 163
>pdb|2HS1|A Chain A, Ultra-High Resolution X-Ray Crystal Structure Of Hiv-1
Protease V32i Mutant With Tmc114 (Darunavir) Inhibitor
pdb|2HS1|B Chain B, Ultra-High Resolution X-Ray Crystal Structure Of Hiv-1
Protease V32i Mutant With Tmc114 (Darunavir) Inhibitor
pdb|3NU4|A Chain A, Crystal Structure Of Hiv-1 Protease Mutant V32i With
Antiviral Drug Amprenavir
pdb|3NU4|B Chain B, Crystal Structure Of Hiv-1 Protease Mutant V32i With
Antiviral Drug Amprenavir
pdb|4FM6|B Chain B, Hiv-1 Protease Mutant V32i Complexed With Reaction
Intermediate
pdb|4FM6|A Chain A, Hiv-1 Protease Mutant V32i Complexed With Reaction
Intermediate
Length = 99
Score = 26.6 bits (57), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 13/42 (30%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ +++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTIIEEMSLPGRWKPKMIG-GIGGFIKVRQY 59
>pdb|3S43|B Chain B, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Amprenavir
pdb|3S53|A Chain A, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Darunavir In Space Group P212121
pdb|3S53|B Chain B, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Darunavir In Space Group P212121
pdb|3S54|A Chain A, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Darunavir In Space Group P21212
pdb|3S54|B Chain B, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Darunavir In Space Group P21212
pdb|3S56|A Chain A, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Saquinavir
pdb|3S56|B Chain B, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Saquinavir
Length = 99
Score = 26.2 bits (56), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 13/42 (30%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ +++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTIIEEMSLPGRWKPKMVG-GIGGFIKVRQY 59
>pdb|3S43|A Chain A, Hiv-1 Protease Triple Mutants V32i, I47v, V82i With
Antiviral Drug Amprenavir
Length = 99
Score = 26.2 bits (56), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 13/42 (30%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 24 VKEAFQEEGVDEQVLQE--LKHIWEAKLFGIGVGKLSKRKEW 63
+KEA + G D+ +++E L W+ K+ G G+G K +++
Sbjct: 19 LKEALLDTGADDTIIEEMSLPGRWKPKMVG-GIGGFIKVRQY 59
>pdb|1BRL|A Chain A, Three-Dimensional Structure Of Bacterial Luciferase From
Vibrio Harveyi At 2.4 Angstroms Resolution
pdb|1LUC|A Chain A, Bacterial Luciferase
pdb|1BRL|C Chain C, Three-Dimensional Structure Of Bacterial Luciferase From
Vibrio Harveyi At 2.4 Angstroms Resolution
pdb|3FGC|A Chain A, Crystal Structure Of The Bacterial Luciferase:flavin
Complex Reveals The Basis Of Intersubunit Communication
pdb|3FGC|C Chain C, Crystal Structure Of The Bacterial Luciferase:flavin
Complex Reveals The Basis Of Intersubunit Communication
Length = 355
Score = 25.8 bits (55), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 11/40 (27%), Positives = 22/40 (55%)
Query: 3 GTPQSLTMKLYQAVIADVINNVKEAFQEEGVDEQVLQELK 42
GTP+ + Q + A I+N+ F+ G +E+++ +K
Sbjct: 302 GTPEECIAIIQQDIDATGIDNICCGFEANGSEEEIIASMK 341
>pdb|2WAU|A Chain A, Structure Of Dbl6 Epsilon Domain From Var2csa
pdb|2WAU|B Chain B, Structure Of Dbl6 Epsilon Domain From Var2csa
Length = 302
Score = 25.8 bits (55), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 12/70 (17%)
Query: 47 AKLFGIGVGKLSKRKEW--MSKCY-RSSNISGRPSLSGNLKARLVYQPCLTQPVELLSIC 103
K+ G GVG+ KRK+W M+K + S +SG GN+ ++L I
Sbjct: 118 GKILGDGVGQNEKRKKWWDMNKYHIWESMLSGYKHAYGNISE---------NDRKMLDIP 168
Query: 104 AADHELQAIR 113
D E Q +R
Sbjct: 169 NNDDEHQFLR 178
>pdb|4A3C|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 5nt
Dna-Rna Hybrid
pdb|4A3B|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 4nt
Dna-Rna Hybrid
pdb|4A3D|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 6nt
Dna-Rna Hybrid
pdb|4A3E|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 5nt
Dna-Rna Hybrid And Soaked With Ampcpp
pdb|4A3F|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 6nt
Dna-Rna Hybrid And Soaked With Ampcpp
pdb|4A3J|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 2nt
Dna-Rna Hybrid And Soaked With Gmpcpp
pdb|4A3K|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 7nt
Dna-Rna Hybrid
pdb|4A3L|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 7nt
Dna-Rna Hybrid And Soaked With Ampcpp
pdb|4A3M|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 4nt
Dna-Rna Hybrid And Soaked With Ampcpp
pdb|4A3G|A Chain A, Rna Polymerase Ii Initial Transcribing Complex With A 2nt
Dna-Rna Hybrid
pdb|4A3I|A Chain A, Rna Polymerase Ii Binary Complex With Dna
pdb|4A93|A Chain A, Rna Polymerase Ii Elongation Complex Containing A Cpd
Lesion
Length = 1732
Score = 25.4 bits (54), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 35 EQVLQELKHIWEAKLFGIGVGKLSKRKEWM 64
E++L KHI +G ++ R EWM
Sbjct: 205 EEILNIFKHISVKDFTSLGFNEVFSRPEWM 234
>pdb|1I3Q|A Chain A, Rna Polymerase Ii Crystal Form I At 3.1 A Resolution
pdb|1I50|A Chain A, Rna Polymerase Ii Crystal Form Ii At 2.8 A Resolution
pdb|1I6H|A Chain A, Rna Polymerase Ii Elongation Complex
pdb|1K83|A Chain A, Crystal Structure Of Yeast Rna Polymerase Ii Complexed
With The Inhibitor Alpha Amanitin
pdb|1NIK|A Chain A, Wild Type Rna Polymerase Ii
pdb|1NT9|A Chain A, Complete 12-Subunit Rna Polymerase Ii
pdb|1PQV|A Chain A, Rna Polymerase Ii-Tfiis Complex
pdb|1R5U|A Chain A, Rna Polymerase Ii Tfiib Complex
pdb|1SFO|A Chain A, Rna Polymerase Ii Strand Separated Elongation Complex
pdb|1R9S|A Chain A, Rna Polymerase Ii Strand Separated Elongation Complex,
Matched Nucleotide
pdb|1R9T|A Chain A, Rna Polymerase Ii Strand Separated Elongation Complex,
Mismatched Nucleotide
pdb|1TWA|A Chain A, Rna Polymerase Ii Complexed With Atp
pdb|1TWC|A Chain A, Rna Polymerase Ii Complexed With Gtp
pdb|1TWF|A Chain A, Rna Polymerase Ii Complexed With Utp At 2.3 A Resolution
pdb|1TWG|A Chain A, Rna Polymerase Ii Complexed With Ctp
pdb|1TWH|A Chain A, Rna Polymerase Ii Complexed With 2'datp
pdb|1WCM|A Chain A, Complete 12-Subunit Rna Polymerase Ii At 3.8 Ang
pdb|1Y1W|A Chain A, Complete Rna Polymerase Ii Elongation Complex
pdb|1Y77|A Chain A, Complete Rna Polymerase Ii Elongation Complex With
Substrate Analogue Gmpcpp
pdb|1Y1V|A Chain A, Refined Rna Polymerase Ii-tfiis Complex
pdb|1Y1Y|A Chain A, Rna Polymerase Ii-Tfiis-DnaRNA COMPLEX
pdb|2B63|A Chain A, Complete Rna Polymerase Ii-Rna Inhibitor Complex
pdb|2B8K|A Chain A, 12-Subunit Rna Polymerase Ii
pdb|2E2H|A Chain A, Rna Polymerase Ii Elongation Complex At 5 Mm Mg2+ With Gtp
pdb|2E2I|A Chain A, Rna Polymerase Ii Elongation Complex In 5 Mm Mg+2 With 2'-
Dgtp
pdb|2E2J|A Chain A, Rna Polymerase Ii Elongation Complex In 5 Mm Mg+2 With
Gmpcpp
pdb|2NVQ|A Chain A, Rna Polymerase Ii Elongation Complex In 150 Mm Mg+2 With
2'dutp
pdb|2NVT|A Chain A, Rna Polymerase Ii Elongation Complex In 150 Mm Mg+2 With
Gmpcpp
pdb|2NVX|A Chain A, Rna Polymerase Ii Elongation Complex In 5 Mm Mg+2 With 2'-
Dutp
pdb|2NVY|A Chain A, Rna Polymerase Ii Form Ii In 150 Mm Mn+2
pdb|2NVZ|A Chain A, Rna Polymerase Ii Elongation Complex With Utp, Updated
112006
pdb|2JA5|A Chain A, Cpd Lesion Containing Rna Polymerase Ii Elongation Complex
A
pdb|2JA6|A Chain A, Cpd Lesion Containing Rna Polymerase Ii Elongation Complex
B
pdb|2JA7|A Chain A, Cpd Lesion Containing Rna Polymerase Ii Elongation Complex
C
pdb|2JA7|M Chain M, Cpd Lesion Containing Rna Polymerase Ii Elongation Complex
C
pdb|2JA8|A Chain A, Cpd Lesion Containing Rna Polymerase Ii Elongation Complex
D
pdb|2YU9|A Chain A, Rna Polymerase Ii Elongation Complex In 150 Mm Mg+2 With
Utp
pdb|2R7Z|A Chain A, Cisplatin Lesion Containing Rna Polymerase Ii Elongation
Complex
pdb|2R92|A Chain A, Elongation Complex Of Rna Polymerase Ii With Artificial
Rdrp Scaffold
pdb|2R93|A Chain A, Elongation Complex Of Rna Polymerase Ii With A Hepatitis
Delta Virus-Derived Rna Stem Loop
pdb|2VUM|A Chain A, Alpha-Amanitin Inhibited Complete Rna Polymerase Ii
Elongation Complex
pdb|3CQZ|A Chain A, Crystal Structure Of 10 Subunit Rna Polymerase Ii In
Complex With The Inhibitor Alpha-Amanitin
pdb|3FKI|A Chain A, 12-Subunit Rna Polymerase Ii Refined With Zn-Sad Data
pdb|3GTG|A Chain A, Backtracked Rna Polymerase Ii Complex With 12mer Rna
pdb|3GTJ|A Chain A, Backtracked Rna Polymerase Ii Complex With 13mer Rna
pdb|3GTK|A Chain A, Backtracked Rna Polymerase Ii Complex With 18mer Rna
pdb|3GTL|A Chain A, Backtracked Rna Polymerase Ii Complex With 13mer With G<>u
Mismatch
pdb|3GTM|A Chain A, Co-Complex Of Backtracked Rna Polymerase Ii With Tfiis
pdb|3GTO|A Chain A, Backtracked Rna Polymerase Ii Complex With 15mer Rna
pdb|3GTP|A Chain A, Backtracked Rna Polymerase Ii Complex With 24mer Rna
pdb|3GTQ|A Chain A, Backtracked Rna Polymerase Ii Complex Induced By Damage
pdb|3H3V|B Chain B, Yeast Rnap Ii Containing Poly(A)-Signal Sequence In The
Active Site
pdb|3HOU|A Chain A, Complete Rna Polymerase Ii Elongation Complex I With A T-U
Mismatch
pdb|3HOU|M Chain M, Complete Rna Polymerase Ii Elongation Complex I With A T-U
Mismatch
pdb|3HOV|A Chain A, Complete Rna Polymerase Ii Elongation Complex Ii
pdb|3HOW|A Chain A, Complete Rna Polymerase Ii Elongation Complex Iii With A
T-U Mismatch And A Frayed Rna 3'-Uridine
pdb|3HOX|A Chain A, Complete Rna Polymerase Ii Elongation Complex V
pdb|3HOY|A Chain A, Complete Rna Polymerase Ii Elongation Complex Vi
pdb|3HOZ|A Chain A, Complete Rna Polymerase Ii Elongation Complex Iv With A
T-U Mismatch And A Frayed Rna 3'-Guanine
pdb|3I4M|A Chain A, 8-oxoguanine Containing Rna Polymerase Ii Elongation
Complex D
pdb|3I4N|A Chain A, 8-oxoguanine Containing Rna Polymerase Ii Elongation
Complex E
pdb|3K1F|A Chain A, Crystal Structure Of Rna Polymerase Ii In Complex With
Tfiib
pdb|3K7A|A Chain A, Crystal Structure Of An Rna Polymerase Ii-Tfiib Complex
pdb|3M3Y|A Chain A, Rna Polymerase Ii Elongation Complex C
pdb|3M4O|A Chain A, Rna Polymerase Ii Elongation Complex B
pdb|3PO2|A Chain A, Arrested Rna Polymerase Ii Elongation Complex
pdb|3PO3|A Chain A, Arrested Rna Polymerase Ii Reactivation Intermediate
pdb|3QT1|A Chain A, Rna Polymerase Ii Variant Containing A Chimeric Rpb9-C11
Subunit
pdb|3RZD|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt Rna
pdb|3RZO|A Chain A, Rna Polymerase Ii Initiation Complex With A 4-Nt Rna
pdb|3S14|A Chain A, Rna Polymerase Ii Initiation Complex With A 6-Nt Rna
pdb|3S15|A Chain A, Rna Polymerase Ii Initiation Complex With A 7-Nt Rna
pdb|3S16|A Chain A, Rna Polymerase Ii Initiation Complex With An 8-Nt Rna
pdb|3S17|A Chain A, Rna Polymerase Ii Initiation Complex With A 9-Nt Rna
pdb|3S1M|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt Rna
(Variant 1)
pdb|3S1N|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt Rna
(Variant 2)
pdb|3S1Q|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt 3'-Deoxy
Rna Soaked With Atp
pdb|3S1R|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt 3'-Deoxy
Rna Soaked With Gtp
pdb|3S2D|A Chain A, Rna Polymerase Ii Initiation Complex With A 5-Nt Rna
Containing A 5br- U
pdb|3S2H|A Chain A, Rna Polymerase Ii Initiation Complex With A 6-Nt Rna
Containing A 2[prime]-Iodo Atp
pdb|4BBR|A Chain A, Structure Of Rna Polymerase Ii-tfiib Complex
pdb|4BBS|A Chain A, Structure Of An Initially Transcribing Rna Polymerase Ii-
Tfiib Complex
Length = 1733
Score = 25.4 bits (54), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 35 EQVLQELKHIWEAKLFGIGVGKLSKRKEWM 64
E++L KHI +G ++ R EWM
Sbjct: 205 EEILNIFKHISVKDFTSLGFNEVFSRPEWM 234
>pdb|2WC5|A Chain A, Structure Of Bmori Gobp2 (General Odorant Binding
Protein 2)
Length = 142
Score = 25.4 bits (54), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 11/38 (28%), Positives = 19/38 (50%)
Query: 8 LTMKLYQAVIADVINNVKEAFQEEGVDEQVLQELKHIW 45
+T ++ V A ++E +E G+ +L E KH W
Sbjct: 1 MTAEVMSHVTAHFGKTLEECREESGLSVDILDEFKHFW 38
>pdb|3J0K|A Chain A, Orientation Of Rna Polymerase Ii Within The Human
Vp16-Mediator-Pol Ii-Tfiif Assembly
Length = 1455
Score = 25.4 bits (54), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 35 EQVLQELKHIWEAKLFGIGVGKLSKRKEWM 64
E++L KHI +G ++ R EWM
Sbjct: 205 EEILNIFKHISVKDFTSLGFNEVFSRPEWM 234
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.132 0.383
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 3,454,205
Number of Sequences: 62578
Number of extensions: 123054
Number of successful extensions: 467
Number of sequences better than 100.0: 147
Number of HSP's better than 100.0 without gapping: 7
Number of HSP's successfully gapped in prelim test: 140
Number of HSP's that attempted gapping in prelim test: 453
Number of HSP's gapped (non-prelim): 154
length of query: 123
length of database: 14,973,337
effective HSP length: 85
effective length of query: 38
effective length of database: 9,654,207
effective search space: 366859866
effective search space used: 366859866
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 45 (21.9 bits)